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The dairy cow experiences a period of immunosuppression around the time of calving 
that contributes to the increased incidence and severity of infectious diseases observed 
during this period. This reduction in immune capacity is due in part to the impairment of 
neutrophil function, a key component of the innate immune system. In fact, the success of 
the host defense mechanisms against infection depends on the ability of neutrophils to 
reach the site of the infection, recognize, engulf and ultimately destroy the pathogen 
using several mechanisms such as the generation and release of reactive oxygen species 
(ROS) and the recently described neutrophil extracellular traps or NETs. The alteration in 
some of these functions and the overall killing ability of neutrophils during the 
periparturient period has been widely described. However, the physiological mechanisms 
underlying the period of immunosuppression are not completely elucidated. Interestingly, 
the impairment of these immune defense mechanisms coincides with the profound 
metabolic changes associated with parturition and lactogenesis. Changes in several 
hormones and metabolites have been proposed to be the cause of the reduction in 
neutrophil function, but the effect of insulin on the functional capacity of these cells has 
not been investigated. Not only does the concentration of plasma insulin fall as 
parturition approaches, but also the animal experiences a period of impaired insulin 
action, termed insulin resistance, during this same time-frame. Therefore, we isolated 
circulating neutrophils from periparturient and midlactating cows and incubated them 
with insulin alone or in combination with the insulin-sensitizing agent 2,4-
thiazolidinedione (TZD). Subsequently, we measured the total, extracellular, and 
intracellular generation of ROS, NETs release, phagocytic and killing ability. Insulin did 
not improve any of the parameters used to assess neutrophil function. In contrast, TZD 
had a potent inhibitory effect on the total ROS generation, despite an increase in 
extracellular superoxide anion production. Surprisingly, TZD did not alter the ability of  
neutrophils to phagocytose and/or kill Staphylococcus aureus during an in vitro co-
culture. Results suggest that TZD can reduce the oxidative stress that neutrophils 
experience during their respiratory burst and diminish the damage that ROS cause to the 






Material from this thesis has been submitted for publication to the Journal of Dairy 
Science on September 15th, 2008 in the following form: 
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CHAPTER ONE: REVIEW OF LITERATURE 
INTRODUCTION 
Infectious diseases such as mastitis and metritis reduce the profitability of dairy 
farming due to treatment cost, decreased milk production, and extra labor (Bartlett et al., 
1990). For instance, the losses due to mastitis alone are estimated at over 2 billion dollars 
annually in the US (NMC, 1996). Remarkably, 75% of disease in dairy cows occurs 
during the periparturient period which is considered to last from 3 weeks before to 3 
weeks after parturition (LeBlanc et al., 2006). This increased incidence of diseases is due 
in part to a period of immunosuppression that occurs for several weeks around the time of 
calving (Mallard et al., 1998). Furthermore, the resolution of clinical cases of mastitis is 
determined by cow factors and depends in particular on the capacity of 
polymorphonuclear cells (PMN) or neutrophils to migrate into the mammary gland, and 
subsequently phagocytose and kill bacteria (Vangroenweghe et al., 2005). Impairment of 
these processes results in a period of reduced immunological capacity or 
immunosuppression around the time of calving (Shuster et al., 1996). Despite 
considerable research, the understanding of the physiological mechanisms that control 
this reduced immunocompetence and the increased severity of infections during the 
periparturient period remains unclear (Paape et al., 2002), although changes in  endocrine 
and metabolic factors that occur during this period seem to have a negative effect on 
neutrophil number and functionality (Burvenich et al., 1999, Scalia et al., 2006, 
Suriyasathaporn et al., 2000). Interestingly, this period of immune suppression coincides 
with a period of reduced circulating insulin concentration and development of insulin 
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resistance. There is evidence from studies with humans that insulin can improve the 
ability of neutrophils to kill pathogens (Walrand et al., 2006), but the effects of this 
hormone on neutrophil function have not been investigated in dairy cows. Thus, the 
elucidation of endocrine factors that contribute to periparturient immunosuppression and 
the development of novel strategies to modulate these factors, may offer promise for 
preventing infectious diseases in dairy cows.  
ROLE OF NEUTROPHILS DURING INFECTION 
Mammary gland defense mechanisms can be placed into two categories: adaptive and 
innate immunity. In the case of clinical mastitis, innate immunity attempts to immediately 
control the intramammary infection (IMI) during the early stages of infection whereas the 
adaptive immune system responds to the challenge with a high degree of specificity 
several weeks after initial exposure to the antigen if the innate defense mechanisms fail to 
completely eliminate the pathogen. The components of innate immunity include primary 
barriers that protect the host (e.g. skin, mucosal membranes, acidity of the stomach, 
perspiration, etc.), soluble factors (including the complement system, the enzyme 
lysozyme, and interferon proteins) and cellular components such as neutrophils, 
macrophages, and natural killer cells. Importantly, the total number and activity of 
neutrophils and macrophages play an early role in determining the severity and duration 
of the infection (Sordillo and Streicher, 2002). Following bacterial invasion, TOLL-like 
receptors (TLR), expressed on the cellular membrane of macrophages and other antigen-
presenting cells, recognize and bind the pathogen-associated molecular patterns (PAMP) 
in order to release chemoattractants and initiate the migration of blood neutrophils to the 
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site of infection (Werling et al., 2006). In fact, Saad and Ostensson (1990) infused 
endotoxin through the teat canal of one udder quarter of healthy cows and determined by 
cytofluorometric analysis that 74% of the total leukocytes present in milk before infusion 
were macrophages and monocytes whereas neutrophils are the predominant leukocyte 
population between 6 and 59 hours after the endotoxin challenge increasing up to 91% at 
27 hours post-infusion. In the presence of bacteria, activated phagocytes and epithelial 
cells produce and release endotoxin, complement-cleavage product C5a, TNF-α, 
interleukin-1 (Il-1), Il-2, Il-8, and interferons that trigger the initiation of the 
inflammatory reaction. Once circulating neutrophils sense these chemotactic compounds, 
they migrate up the concentration gradient of these chemoattractants, roll and adhere to 
vascular endothelium with the assistance of adhesion molecules. Adhesion molecules 
such as E-selectin, leukocyte integrin (ICAM-1), CD11a:CD18 (LFA-1) and S-Le are 
critical in the migration of the PMN through the vessel wall (Paape et al., 2002, 
Suriyasathaporn et al., 2000). Extravasation or diapedesis of phagocytes is a sequential 
process beginning with tethering mediated by low-affinity binding of selectin molecules 
that slow the neutrophils at the vessel wall. This low-affinity binding causes neutrophils 
to roll along the endothelial lining until L-selectin and β2-integrin become activated, 
enhancing affinity that promotes firm adhesion, transendothelial migration and  finally 
de-adhesion (Diez-Fraile et al., 2002).  
Once the activated neutrophils cross the blood-milk barrier, they migrate up the 
gradient of the chemoattractant and express increased levels of Fc receptors for antibody 
and complement that enable them to bind more effectively to pathogens coated with such 
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opsonins. Although not essential for phagocytosis, opsonization promotes the uptake of 
pathogens by neutrophils (Paape et al., 2002). For instance, Guidry et al. (1993) reported 
that in-vitro phagocytosis of Staphylococcus aureus by neutrophils isolated from blood 
was 57.9 and 32.1% increased when the bacteria were opsonized with IgM and IgG2, 
respectively, compared to PMN phagocytosis of non-opsonized S. aureus. Neutrophils 
use their TLR and other pattern recognition receptors to bind and engulf opsonized 
pathogens and then rely on several killing mechanisms such as the action of potent 
oxidants (e.g. intracellular and extracellular release of reactive oxygen species), granular 
enzymes-peptides (Paape et al., 2002) and neutrophil extracellular trap destructive 
machinery (Brinkmann et al., 2004) to eliminate the invading microorganisms. Therefore, 
during an IMI, the success of the innate immune response depends on rapid recognition 
of the pathogen, migration of PMN to the mammary gland and the effectiveness of the 
cellular and humoral killing mechanisms (Burvenich et al., 2007).   
Neutrophil killing mechanisms 
Neutrophils play a key role in the resolution of intrammary infection by host 
defense mechanisms and have been the focus of intense research (Paape et al., 2003). 
Several lines of investigation have demonstrated that neutrophils are critical to fight a 
pathogenic insult. For example, Schalm et al. (1976) infused S. aureus in mammary 
quarters of 4 lactating cows to establish chronic mastitis and subsequently administered 
anti-bovine leukocyte serum that resulted in severe neutropenia in blood and depletion of 
neutrophil reserves in the bone marrow. Although this observational study lacked an 
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appropriate control group, the disappearance of neutrophils from blood and bone marrow 
in these animals was followed by the development of gangrenous mastitis that even 
resulted in the death of one of the cows as soon as 16 hours after neutropenia. 
Impairement of the neutrophil’s ability to adhere to and cross the endothelial cell lining 
as well as migrate to the site of the infection favors uncontrolled pathologic processes. In 
fact, the genetic disorder known as bovine leukocyte adhesion deficiency (BLAD; 
characterized by reduced expression of the adhesion molecule integrin and a lower ability 
of PMN to migrate across bovine endothelial cell monolayers), usually results in chronic 
bacterial infections and premature death (Olchowy et al., 1994). Although the mammary 
gland posses several antimicrobial defense systems, it is the massive influx of PMNs that 
will resolve the infection  through their killing mechanisms, including the production and 
release of reactive oxygen species (ROS), reactive nitrogen species (RNS) and the 
recently described extracellular traps or NETS (Burvenich et al., 2003). 
 Production of reactive oxygen species (ROS) 
The neutrophil is a phagocytic granulocyte generated by the multistep processes 
of granulopoiesis beginning from a common myeloid precursor and progressing through 
myeloblast, promyelocyte, myelocyte, metamyelocyte and band cell stages. 
Granulopoiesis occurs in the bone marrow and includes changes in cell size, nuclear 
shape and development of granular proteins (Burvenich et al., 2003). Once in circulation, 
the neutrophil has a short half-life of approximately 8 or 9 hours (Paape et al., 2002). 
Mature neutrophils have a polymorphic segmented nucleus that allows the cell to line up 
its nuclear lobes to facilitate the rapid migration between endothelial cells. Within its 
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cytoplasm, the neutrophil has large islets of glycogen and several types of granules that 
contain antimicrobial compounds. Bovine neutrophils have azurophilic or primary 
granules that contain the enzyme peroxidase involved in the production of reactive 
oxygen species (ROS), specific or secondary granules (less electron dense than the 
primary granules) and “novel”  granules with the majority of antimicrobial protein 
activity (Paape et al., 2003).  
Neutrophils have a dramatic increase in the turnover of the hexose 
monophosphate shunt and the production of several ROS after cell activation. This 
respiratory burst activity is non-mitochondrial and is mediated by the enzyme complex 
NADPH oxidase (Shepherd, 1986). The core component of the NADPH oxidase, the 
flavocytochrome b558, is distributed between the plasma membrane and the membrane of 
specific granules when the cell is in rest. Upon activation, this component is incorporated 
into the wall of the phagocytic vacuole where it carries electrons from NADPH in the 
cytoplasm to O2 inside the vacuole. In order to facilitate electron transport through the 
flavocytochrome, it must interact with other components of the complex such as the 
proteins p67phox, p47phox, p40phox and p21rac, that also translocate to the membrane 
of the vacuole (Segal, 2005). Thus, the NADPH oxidase complex catalyzes the 
consumption of O2 via electron transfer from NADPH to O2 resulting in the generation of 
superoxide anion (O2─). In turn, superoxide dismutase converts O2─ to H2O2 which is the 
main precursor of neutrophil ROS (Hodgson et al., 2006). The enzyme myeloperoxidase 
forms a complex with H2O2 that attacks the pathogen directly or reacts with nitrogen 
intermediates to form highly reactive compounds (Shepherd, 1986). In fact, the enzyme 
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nitric oxidase synthase catalyzes the conversion of L-arginine to citrulline with the 
concomitant release of reactive nitrogen species (RNS) such as nitric oxide, which is 
oxidized to nitrite and nitrate. The lysosomal vacuoles containing ROS and RNS will fuse 
with phagosomes, which are vacuoles originating from the extracellular surface 
containing engulfed (phagocytosed) bacteria and extracellular fluid components.  The 
fusion of the lysosome with the phagosome creates a phagolysosome in which the 
bacteria can be killed. 
Polymorphonuclear neutrophils have the capacity to kill bacteria intracellularly or 
extracellularly by oxygen-independent or -dependent mechanisms (oxidative burst). 
Neutrophil killing via extracellular release of ROS is a rather non-specific and inefficient 
method of bacterial killing because these toxic products are released somewhat 
indiscriminately into the infected tissue and may or may not actually come in contact 
with bacteria.  Even though these extracellular reactive oxygen species are toxic to 
bacteria, they also result in severe oxidative stress to mammalian cells. Indeed, 
neutrophils may promote tissue injury and affect mammary function via either ROS 
production or granular enzyme release (Zhao and Lacasse, 2007). In fact, Capuco et al. 
(1986) obtained mammary tissue explants at slaughter from noninfected quarters of 5 
lactating cows and incubated them with intact, lysed or zymozan-activated neutrophils 
isolated from mammary secretions of nulliparous heifers. They reported that after 8 hr in 
culture, control tissue examined by light microscopy was morphologically normal 
whereas PMN-treated explants had degenerated, presenting less alveolar luminal area, 
swollen milk secretory cells with nuclear pyknosis, epithelial vacuolation and filling of 
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luminal areas with cell debris. No differences in tissue morphology were found among 
explants treated with lysed, intact or activated neutrophils, but the magnitude of epithelial 
lysis was greater in those explants incubated with activated PMN. 
 Neutrophil extracellular traps (NETs) 
Neutrophil extracellular traps or NETs were first described by Brinkmann et al. 
(2004) as a novel antimicrobial mechanism of neutrophils. The biology of these NETs is 
not yet completely understood, but it is known that after activation, nuclear components 
with bactericidal properties including the chromatin-histones H1, H2A, H2B, H3 and H4 
as well as degradative enzymes such as elastase, myeloperoxidase and the bactericidal 
permeability increasing protein (BPI) are secreted into the extracellular matrix to 
physically trap the microorganism and provide a high local concentration of molecules 
that effectively kill the pathogen. Brinkmann and colleagues also suggested that DNA is a 
major structural component of NETs since treatment with deoxyribonuclease resulted in 
disintegration of NETs. Recently, Fuchs et al. (2007) reported that NETs emerge from 
dying neutrophils in a process different from apoptosis and necrosis. Approximately 2 
hours after activation, the cells lose their nuclear and granular membranes allowing the 
mixing of granular components and chromatin followed by the rupture of the cell 
membrane and release of NETs into the intracellular space. These neutrophils neither 
presented a necrotic morphology nor showed signs of DNA fragmentation. However, it is 
still in debate whether this mechanism used by neutrophils to form and release NETs is 
similar to that of cell division (Brinkmann and Zychlinsky, 2007). Importantly, Urban et 
al. (2006) found direct evidence that NETs have anti-microbial properties. They 
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incubated PMN with the yeast Candida albicans for 2 hours and determined colony-
forming units to estimate total and extracellular killing by neutrophils, and reported a 
reduction of total killing from 84% to 48% when DNase was added to digest any formed 
NETs. 
Recent studies have also indicated that bovine neutrophils may set extracellular 
traps (NETs) that effectively kill bacteria in milk (Lippolis et al., 2006b). Interestingly, 
NETs secreted by bovine PMN collected from blood are as effective in eliminating 
bacteria in milk as they are in media. This unchanged killing capacity in milk versus 
blood is contrary to other killing mechanisms of neutrophils, and suggests that NETs may 
be an important mechanism of defense of the bovine mammary gland. 
PERIPARTURIENT IMMUNOSUPPRESSION  
The periparturient period between late pregnancy and early lactation, also known 
as the transition period, has dramatic effects on the metabolism and health of the dairy 
cow. The main challenge faced by the animal during this time is the increase of nutrient 
requirements for milk production at a time when nutrient intake is not sufficient to meet 
these requirements (Bell, 1995). Remarkably, most infectious diseases and metabolic 
disorders occur during this short period of time considered to last from 3 wk before 
parturition until 3 wk after parturition (Drackley, 1999). One of the most important 
advances in the last 25 years of disease investigation in dairy cattle is the recognition of 
this transition period as critical for disease prevention in dairy cattle (LeBlanc et al., 
2006). Indeed, it has been established that the alterations in immune defense mechanisms 
10 
 
are centered in this period (Mallard et al., 1998) coincide with the metabolic challenges 
associated with parturition and the onset of lactation. In fact, the number of new cases of 
clinical mastitis seems to be considerably higher during the first week of lactation 
compared to those detected from the second week onward in primiparous and 
multiparous cows (Wilson et al., 2004).  
Dairy cows are especially susceptible to intramammary infections during the 
periparturient period not only because the number of circulating mature neutrophils is 
lower, but also due to a reduction of polymorphonuclear neutrophil functions including 
phagocytosis, respiratory burst activity, superoxide anion production, random migration 
and chemotaxis (Cai et al., 1994). In fact, Shuster et al. (1996) challenged cows at 6-10 
days after calving or midlactation with an intramammary infusion of E. coli and reported 
that the peripariparturient animals had more severe clinical signs of mastitis as well as 
more rapid intramammary bacterial growth (~35 fold greater) after 10 hours of 
inoculation compared to the midlactating group. The decrease of neutrophil number and 
functionality during this phase is not well understood and may be partially due to 
multiple endocrine and metabolic factors (Burvenich et al., 1999, Scalia et al., 2006, 
Suriyasathaporn et al., 2000), mineral status (Goff, 2006) or underlying changes in 
expression of key cellular genes (Madsen et al., 2002). Furthermore, periparturient 
immunosuppression is characterized by a greater percentage of immature neutrophils 
released into the blood from the bone marrow (Cai et al., 1994) and these immature cells 




Several lines of research indicate that the respiratory burst activity of neutrophils 
is diminished around the time of calving. Hoeben et al. (2000) isolated neutrophils twice 
weekly from healthy cows (n=8) for a period of 14 weeks around parturition and reported 
that luminol-dependent chemiluminescence (CL) decreased beginning approximately 1 
week before parturition, reached lowest values during the first week postpartum and 
remained low until 5 weeks after parturition. These findings were confirmed by Mehrzad 
et al. (2002) who reported that the production of reactive oxygen species (ROS) 
quantified by a similar CL assay, sharply decreased approximately 3 weeks before 
parturition and stayed low during the first weeks of lactation.    
In addition to the reduction in neutrophil respiratory burst activity, the 
mechanisms regulating the PMN apoptotic pathway may also be altered around the time 
of calving. The percentage of apoptotic neutrophils in blood is higher during the 
periparturient period compared to mid-lactation suggesting that more PMN’s undergo 
apoptosis around parturition (Van Oostveldt et al., 2001). Also, apoptotic cells have a 
decreased respiratory burst and phagocytic activity suggesting that this process might 
contribute to some extent to the reduction of PMN functionality (Van Oostveldt et al., 
2002). In summary, it has been well established that specific mechanisms used by PMNs 
to kill bacteria are impaired during the periparturient period. Several studies have 
reported that PMNs obtained from cows during the periparturient period have a reduced 
capacity to kill gram positive and negative bacteria compared to neutrophils collected 
from midlactating cows (Cai et al., 1994; Daniel et al., 1991; Detilleux et al., 1995; 
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Dosogne et al., 2001; Kehrli et al., 1989) confirming that bovine neutrophil function is 
diminished during this period.     
METABOLIC ADAPTATIONS OF THE PERIPARTURIENT COW 
The periparturient period represents a considerable metabolic challenge to the 
dairy cow due to increased nutrient requirements to support the growth and metabolism 
of the gravid uterus (fetus, fetal membranes, uterine tissues and placenta) and the onset of 
milk secretion. In late pregnancy, maternal amino acids, glucose, lactate and acetate 
supply the fetus with the carbon and nitrogen required for its growth, however, more 
dramatic increases in mammary requirements for glucose, amino acids and fatty acids 
occur after parturition to support milk synthesis (Bell, 1995). In fact, Overton (1998) 
estimated the glucose demand of lactating cows to be approximately 1100 g/d at day 21 
before parturition whereas 21 days after calving, it increased up to 2500 g/d. Despite the 
higher nutrient requirements during the periparturient period, voluntary dry matter intake 
does not increase to the same degree to meet these requirements. Thus, the animal enters 
a state of negative energy balance and must undergo substantial metabolic adjustments to 
support pregnancy and lactation (Bell and Bauman, 1997). 
In the dairy cow, the supply of glucose to extrahepatic tissues depends primarily 
on gluconeogenesis because in ruminants little glucose is absorbed from the 
gastrointestinal tract. As a metabolic adaptation to higher glucose demands, the whole-
body oxidation of glucose decreases whereas gluconeogenesis from endogenous sources 
is enhanced after parturition (Bell, 1995). Reynolds et al. (2003) reported a net glucose 
13 
 
release by the liver of 294, 317, 627, 777 and 810  mmol/h at days -19, -9, 11, 21 and 33 
relative to parturition, respectively. Even though liver mass changes and transfer of 
nutrients across membranes are also upregulated, most of the increased flux of nutrients 
relies on a higher hepatic metabolic activity (Drackley et al., 2001).  
Changes in fatty acid metabolism, including the massive mobilization of 
triacylglycerols (TG) from fat tissue, are necessary when energy intake is insufficient to 
support maintenance and milk production. The hydrolysis of stored TG yields one 
molecule of glycerol and three fatty acids which can be released into the bloodstream as 
non-esterified fatty acids (NEFA). In fact, plasma NEFA increases approximately 
twofold between 17 and 2 days before parturition and twofold again at calving 
(Grummer, 1993). Since hepatic fatty acid uptake is dependent upon NEFA concentration 
in blood, the liver is challenged around parturition with an increased supply of NEFA. 
Drackley et al. (2001) estimated a NEFA entry rate of 13.45 mol/day into the circulation 
of a cow producing 31.9 kg of milk a day at 4 wk of lactation, of which approximately 
25% may be taken up by the liver. Assuming that a certain amount of these NEFA is 
oxidized by the hepatocytes, they concluded that 525 g/d of NEFA would be available for 
re-esterification or ketogenesis. Plasma NEFA are highly correlated with lipolysis and 
can be used as an indicator of energy balance (Mashek et al., 2001). Thus, NEFA are 
oxidized by the liver to produce reducing equivalents, used for hepatic TG synthesis and 
export as VLDL or converted to ketone bodies. These ketone bodies can be ultimately 
utilized for oxidation by the heart, kidney, skeletal tissue and gastrointestinal tract or as 
substrates for mammary gland de-novo fatty acid synthesis (Drackley et al., 2001). 
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Endocrine regulation  
Bauman and Currie (1980) defined homeorhesis as the coordinated changes in 
metabolism to support a physiological state such as pregnancy and/or lactation. These 
physiological adaptations must be mediated by endocrine regulation including changes in 
hormones as well as altered tissue responses to these humoral factors. Thus, several 
hormones regulate the key non-mammary adaptations during the transition period 
(suppression of peripheral glucose utilization, increase in hepatic gluconeogenesis and 
mobilization of fat stores). Insulin is one of the major regulators of these adaptations, as 
described in the next section. However, different hormones also have either a direct effect 
on glucose and lipid metabolism or indirect effects through alterations in the tissues 
responses to insulin (Bell and Bauman, 1997). 
Growth hormone (GH), also known as somatotropin, plays a pivotal role in the 
development of the mammary gland (ductal morphogenesis), milk synthesis and 
metabolic regulation of periparturient dairy cows. The plasma concentration of GH 
increases during late pregnancy, with a sharp peak at parturition and a post-partum 
decline to moderate levels through early lactation (Bell, 1995). GH binds to its specific 
cell surface receptor which is highly expressed in liver but is also present in other tissues. 
GH can exert its effects directly or via the insulin-like growth factors (IGF-1 and -II) 
released from target tissues upon binding of GH to its receptor. These effects include an 
increase in milk synthesis by the mammary gland, enhanced gluconeogenesis and 
synthesis of protein by the liver, increased lipolysis/reduced lipogenesis and decreased 
utilization of glucose by muscle tissue (Renaville et al., 2002). Exogenous administration 
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of bovine somatotropin (bST) to midlactation cows that results in an increase in milk 
yield, dramatically reduced the rate of lipogenesis and the mRNA expression of the 
lipogenic enzymes acetyl CoA carboxylase and fatty acid synthase (Lanna et al., 1995). 
Similarly, Bauman et al. (1988) injected cows with bST between days 63 and 146 of 
lactation and reported an increase in plasma NEFA (+104 μmol/day) and a reduction in 
whole body glucose oxidation (-0.4 mol/day), compared to control cows injected with an 
excipient. Thus, exogenous GH administration results in marked changes in partitioning 
of nutrients to support higher milk production. Importantly, the GH actions on liver are 
reduced during the periparturient period limiting IGF-1 production whereas its effects on 
muscle and adipose tissue remain intact (Bauman and Vernon, 1993). In fact, the 
expression of GH receptors in liver early in lactation is reduced compared to that of 
midlactation, resulting in a fall of approximately 70% in plasma IGF-1, which is 
primarily produced by hepatic tissues (Wook Kim et al., 2004).  
Epinephrine, norepinephrine, and glucagon to some extent, stimulate lipolysis by 
binding β-adrenergic receptors in adipocytes, resulting in stimulation of adenylate cyclase 
activity and increased production of cyclic AMP with the subsequent activation of protein 
kinase A. In turn, this kinase phosphorylates and activates hormone-sensitive lipase 
which is responsible for the breakdown of TGs into free fatty acids and glycerol (Vernon 
and Pond, 1997). In response to the necessity to mobilize energy from fat stores, the 
sensitivity and responsiveness of adipose tissue to these adrenergic agents is increased 
during the periparturient period (Bell, 1995). Thus, increased lipolysis during lactation is 
mediated in part by decreased serum insulin and increased response to catecholamines.   
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The marked periparturient increase in plasma prolactin and the increase in 
prolactin receptors in the mammary gland that occurs with the onset of lactation are 
essential for the initiation of lactogenesis, including direct effects on ion transport, amino 
acid transport, golgi volume, and synthesis and secretion of milk fat and proteins (Tucker, 
2000). In addition to its role in lactogenesis, prolactin may also regulate the metabolic 
adaptations of transition cows, supporting the partitioning of nutrients towards the 
mammary gland by decreasing synthesis of lipid reserves and increasing mobilization of 
fat stores (Bauman and Currie, 1980).  
Plasma levels of estradiol in dairy cows increase progressively during late 
pregnancy, peaking several days prior to parturition whereas progesterone concentrations 
decrease just before parturition (Bell, 1995). Although the mechanisms are not completed 
elucidated, higher progesterone during pregnancy might increase the sensitivity of 
adipose tissue to insulin resulting in increased glucose uptake and lipogenesis. In 
contrast, during late pregnancy and early lactation, estrogen decreases insulin sensitivity 
and responsiveness to allow increased hepatic gluconeogenesis, reduced lipogenesis and 
reduced protein synthesis in muscle (Bell and Bauman, 1997).    
 Role of insulin in the partitioning of nutrients during the periparturient period 
Insulin is a peptide hormone composed of 51 amino acid residues that is 
synthesized and secreted by the β-pancreatic cells located in clusters of cells known as 
islets of Langerhans. It consists of two peptide chains, termed A and B (21 and 30 amino 
acids, respectively) joined by two disulfide bridges (Owerbach et al., 1980). The 
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production of insulin begins with the synthesis of mRNA in the nucleus of the β-
pancreatic cell followed by the formation of the insulin precursor preproinsulin in the 
rough endoplasm reticulum. This precursor is transferred to the Golgi apparatus and then 
to the secretory granules in the cytoplasm where insulin is stored. Several factors can 
stimulate insulin secretion including nutrients, gastrointestinal hormones, 
parasympathetic stimuli and certain therapeutics (Hayirli, 2006).  
Insulin can influence metabolism indirectly by regulating substrate supply from 
extrahepatic tissues or by controlling homeorhetic adaptations such as gluconeogenesis 
and lipolysis. It promotes the uptake of glucose into muscle and fat tissue, enhances 
incorporation of amino acids into muscle and increases lipogenesis by adipocytes 
(Brockman, 1978). As described earlier, the last stage of pregnancy and the onset of 
lactation require significant metabolic adaptations to meet the increased glucose 
requirements of the gravid uterus or lactating mammary gland. In the dairy cow this 
adaptation is partially accomplished via decreased circulating concentrations of insulin 
during lactation. Prepartum plasma insulin concentration is higher than postpartum (Bell, 
1995, Blum et al., 1973); Smith (2006) reported a decline in plasma insulin from 
approximately 0.67 ng/mL at day 21 before parturition to 0.1 ng/mL on the day of 
calving. After parturition, the hormone levels slowly increase to reach 0.2 ng/mL 3 weeks 
after calving. This lower periparturient insulin concentration is due to a diminished 
pancreatic output rather than any increase in hepatic uptake (Lomax et al., 1979) and is 
one of the metabolic regulations that allow mobilization of stored nutrients to support the 
increased energy demands of lactation.  
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Insulin is the major hormone favoring fatty acid synthesis and lipid accumulation 
in bovine adipose tissue by up-regulation of transcription of genes encoding enzymes 
involved in lipid synthesis such as lipoprotein lipase and acetyl CoA carboxylase and 
stimulation of glucose transport through the translocation of glucose transporters (Vernon 
and Pond, 1997). Thus, the drop in plasma insulin together with the development of 
insulin resistance during the periparturient period, allows the mobilization of fat stores in 
the dairy cows. In fact, exogenous insulin has a profound effect on fatty acid metabolism 
in cows during the transition period. For instance, Mashek et al. (2001) infused insulin at 
a constant rate of 1 μg/kg/hr for 4 days, while maintaining glucose concentration at 
previously determined baseline levels, into cows at weeks 4 and 17 of lactation to 
determine its effects on plasma metabolites and hormones. They reported a decrease of 
259 uEq/L in plasma NEFA in early lactating cows, as well as a reduction in β-
hydroxybutyrate of 0.64 mM regardless of stage of lactation, compared to the pre-
infusion levels.   
Insulin signaling 
Insulin signaling involves several events initiated by hormone binding to its 
receptor which is located in the cell surface. The insulin receptor is a tetramer with two 
alpha and two beta subunits with intrinsic tyrosine kinase activity. After binding, the 
tyrosine residue of the beta subunits are autophosphorylated at several intracellular 
tyrosine residues resulting in a conformational change of the membrane with the 
subsequent phosphorylation of insulin receptor substrate proteins (IRS), and other targets 
such as Shc, Cbl, p62dok and Gab-1, by the insulin receptor tyrosine kinase (Lizcano and 
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Alessi, 2002). Following phosphorylation, these substrates act as docking molecules for 
proteins that contain src homology region 2 (SH2) domains that become activated or 
associate with other downstream molecules resulting in a complicated cascade of events 
(Biddinger and Kahn, 2006). Several intracellular kinases, including the PtdIns 3, MAP, 
S6 and protein kinase C (downstream of PDK-1) are components of the insulin signaling 
and mediate the coupling of the receptor to its downstream effectors to yield numerous 
biological responses (Kim et al., 2003, Wilden and Kahn, 1994). Insulin is a mediator of 
nutrient partitioning, it plays a major role in the regulation of glucose metabolism, 
promotes the cellular utilization of glucose, and also regulates protein and lipid 
metabolism (Hayirli et al., 2002).  
 Insulin resistance 
Insulin resistance develops when normal levels of insulin produce a less than 
normal response either because of decreased sensitivity to the hormone (associated with 
alterations before the interaction with its receptor), or due to a decrease in the maximal 
response to the hormone, related to post-receptor alterations (Kahn, 1978). Even though 
the assessment of insulin resistance focuses on its effects on glucose homeostasis, insulin 
resistance also affects other metabolic processes such as the synthesis and storage of fat, 
protein synthesis and cell growth and differentiation. Furthermore, not all the processes 
and tissues regulated by the hormone become equally resistant to insulin. In fact, it has 
been suggested from studies with insulin receptor knockout mice that insulin resistance in 
fat and muscle is not always detrimental to overall glucose homeostasis, in contrast with 
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the diabetic-ketoacidosis effects of insulin resistance in brain, liver and β-cells (Biddinger 
and Kahn, 2006).     
Reduced sensitivity to insulin of glucose utilization, lipolysis and nonesterified 
fatty acid (NEFA) mobilization, has been observed during late pregnancy in humans, 
laboratory animals and sheep (Bell, 1995) indirectly mediating the enhanced glucose 
synthesis and attenuated glucose utilization in nonuterine and nonmammary tissues (Bell 
and Bauman, 1997). The molecular mechanism of the insulin resistance in lactation, 
including the transcription of genes encoding metabolic enzymes have not been totally 
elucidated (Vernon and Pond, 1997). In fact, most of the evidence on insulin resistance in 
ruminants comes from studies with pregnant and lactating sheep. For instance, Vernon et 
al. (1981) biopsied adipose tissue from the rump of sheep at different physiological stages 
of lactation and found a reduced number of high-affinity and total insulin receptors (both 
receptors per cell and receptors per area of cell surface) in adipocytes by day 105 of 
pregnancy, compared to samples obtained from animals between 70 to 100 days of 
pregnancy. The authors also reported a fall of circulating insulin from 4.29 to 0.87 
ng/mL, suggesting that the changes in the hormone levels and its response machinery 
facilitate the switch to lipid mobilization observed during late pregnancy in sheep. 
Furthermore, muscle insulin resistance has been documented in lactating sheep; Vernon 
et al. (1990) reported that the ability of insulin to stimulate glucose utilization by muscle 
tissue, assessed by glucose arterial-vein difference across the hindlimb, is diminished in 
lactating ewes at ~18 days postpartum compared to non-pregnant non-lactating animals. 
Similarly, Petterson et al. (1994) performed a hyperinsulinemic euglycemic clamp to 
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assess insulin resistance by means of quantifying its antilipolytic effect. They reported a 
reduced responsiveness to the hormone in pregnant ewes compared to nonpregnant sheep 
since the maximal insulin-suppressed concentrations of NEFA and glycerol (Rmax), were 
148 and 64.5 μmol/L, respectively. In beef cows, peripheral tissue responsiveness to 
insulin was lower in late pregnant and lactating animals than in nonpregnant nonlactating 
and  dry cows, respectively (Sano et al., 1990) but tissue responsiveness to insulin 
remained unchanged during lactation in dairy cattle, perhaps as a result of greater weight 
loss in dairy than beef animals during lactation (Sano et al., 1993).  
2,4-Thiazidionelidione, a PPARγ agonist, enhances insulin sensitivity 
PPARγ is a member of the nuclear receptor family highly expressed in adipose 
tissue and immune system. It contains N-terminal, DNA-binding and ligand-binding 
domains. Once the ligand binds to the receptor causing a conformational change, it binds 
to other transcription factors such as the 9-cis-retinoic acid receptor (RXR) to form a 
heterodimer. This complex in turn binds to peroxisome proliferator response elements 
(PPRE) on DNA resulting in the activation of transcription.  PPARγ activation has a role 
in many physiological events such as adipocyte differentiation, stimulation of insulin 
action, regulation of lipid metabolism and effects on inflammatory processes. However, 
the mechanisms underlying these effects have not been completely elucidated 
(Houseknecht et al., 2002).  
Thiazolidinediones (TZDs) are synthetic PPARγ ligands that have anti-
inflammatory effects, improve insulin resistance and lower plasma glucose levels in 
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diabetic humans (Pascual et al., 2007). In dairy cows, Smith et al. (2007) administered 4 
mg/kg BW of 2,4-TZD during the last 25 days of pregnancy and reported that treated 
cows had lower plasma NEFA concentrations compared to controls (70 vs. 83 μEq/L, 
repectively) during the prepartum period and a tendency to be decreased (P<0.06) from 
day 7 before parturition through day 7 postpartum (113 μEq/L for cows treated with TZD 
vs. 205 μEq/L for control animals). Similarly, Kushibiki et al. (2001) found that 2,4-TZD 
administration to steers with recombinant bovine tumor necorsis factor (rbTNF)-induced 
insulin resistance restored insulin-mediated glucose utilization since the calculated area 
under the curve for changes of plasma glucose concentrations after a single dose of i.v. 
insulin was 39.5 and 45.65% smaller in the TNF-treated steers compared to control and 
TNF + TZD steers, respectively.  
Both PPARα and PPARγ are expressed in human mononuclear cells and 
macrophages. In addition to their role in fatty acid metabolism, these PPARs also exert 
direct anti-inflammatory activities (Chinetti et al., 2000). Therefore, their synthetic ligand 
TZD, has been shown to induce a potent anti-inflammatory effect by binding to PPARγ, 
which through DNA-independent mechanisms, interfere with transcription factors 
involved in inflammatory pathways (Yki-Jarvinen, 2004). As an example, Jiang et al. 
(1998) incubated activated human blood peripheral mononuclear cells from 6 donors with 
troglizatone and reported a dose-dependent inhibition of PMA-induced synthesis of the 
inflammatory cytokines TNF-γ, IL-6 and IL-1β. Similarly, incubation of macrophages 
with several types of thiazolidinediones inhibited the mRNA expression of nitric oxidase 
synthase (iNOS), responsible for the generation of reactive nitrogen species (Ricote et al., 
23 
 
1998). Consistent with these effects during in vitro incubations, administration of TZDs 
to healthy subjects has suppressed ROS generation by mononuclear cells and decreased 
the plasma concentrations of TNF-α and IL-6 and the adhesion molecule sICAM 
(Ghanim et al., 2001). These findings suggest a modulatory role for PPARs in the control 
of the inflammatory response with potential therapeutic applications in inflammation-
related diseases (Chinetti et al., 2000). 
EFFECT OF PERIPARTURIENT ENDOCRINE AND METABOLIC CHANGES 
ON IMMUNE CELL FUNCTION 
The periparturient period of dairy cows has the highest incidence and severity of 
infectious diseases due to a period of immunosuppression which coincides with the 
appearance of structural changes in the mammary gland and a metabolic shift from 
anabolism to catabolism, both modulated through changes in concentrations of systemic 
and local hormones (Vangroenweghe et al., 2005). This period of reduced immune 
capacity may not be explained by the reduction of a single independent immune factor.  
Instead, the humoral and metabolic changes associated with the physiological adaptations 
that occur around parturition, seem to affect several functions of various types of immune 
cells (Mallard et al., 1998, Overton and Waldron, 2004). A strong immune response can 
affect the metabolic status of periparturient cows and therefore, it is possible that 
immunosuppression might be an adaptation to lactation, despite its detrimental effects on 
immune processes (Overton and Waldron, 2004).  
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The postpartum negative energy balance (NEB) and the related endocrine changes 
have been proposed to contribute to periparturient immunosuppression. For instance, 
Kimura et al. (1999) hypothesized that removing the nutrient demands of the mammary 
gland via mastectomy while maintaining endocrine and other changes associated with 
parturition would eliminate the reduction of neutrophil function after calving. There was 
no difference in leukocyte counts between mastectomized and intact cows and the 
elimination of milk production didn’t prevent the decline of myeloperoxidase activity 
during the last 3 weeks of pregnancy, but mastectomized animals had a rapid recovery of 
myeloperoxidase activity after parturition compared to controls. In contrast with these 
results, Perkins et al. (2001) fed Holstein steers either a positive or negative energy 
balance diet (210 and 60% of maintenance requirements) in a crossover design with two 
treatment periods of 3 weeks separated by an adaptation period of 2 weeks. They reported 
that the negative energy balance had no effect on the mean fluorescence intensity 
associated with the expression of the adhesion molecules CD11b, CD18 and MHC class 
I, but modestly increased the expression of CD62L and MHC class II on neutrophils and 
leukocytes, respectively. The same investigators (2002) infused endotoxin into one 
mammary quarter of midlactating cows fed ad libitum or at 80% of maintenance energy 
requirements. Intramammary infusion elicited a local and systemic inflammatory 
response including a 60% reduction in blood leukocyte counts and an increase in milk 
somatic cell counts, but there was no effect of feed restriction on blood total leukocyte 
counts, rumen motility, serum TNF-α or milk IgG concentrations. Furthermore, Stabel et 
al. (2003) increased the dietary energy intake of periparturient cows with Johne’s disease 
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by mechanically stuffing refused feed into fistulated cows. They reported no differences 
in chemotaxis and iodination of neutrophils collected from these cows compared to 
neutrophils isolated from cows fed ad libitum. Together, these findings suggest that the 
negative energy balance per se that dairy cows experience during the periparturient 
period has little or no effect on immunosuppression. However the presence of the 
mammary gland and the metabolic demands of lactogenesis seem to contribute to this 
period of reduced immune competence. 
There is also evidence that the changes in fatty acid metabolism around 
parturition associated with high levels of non-esterified fatty acids (NEFAs) and ketone 
bodies impair immunity even though the mechanisms of this effect is still unknown 
(Suriyasathaporn et al., 2000). For example, the myeloperoxidase activity of blood 
neutrophils, and cytochrome c reduction, both indexes of ROS production, were impaired 
in cows with puerperal metritis and subclinical endometritis that showed higher NEFA 
levels during the same period (Hammon et al., 2006). The authors reported a negative 
correlation (R = 0.44) between plasma NEFA levels and myeloperoxidase activity for 
these animals. Although these results do not establish a cause-effect relationship, the 
negative effect of NEFA on neutrophil function has been confirmed by Scalia et al. 
(2006) who reported that incubation of bovine neutrophils with high (2 and 1mM), 
moderate (0.5 and 0.25mM) or low (0.125 and 0.0625mM) concentrations of NEFA 
resulted in a ~11% reduction in oxidative burst activity in those cells incubated with low 
and moderate levels of NEFA whereas the highest concentration of NEFA resulted in an 
increase of necrosis with a concomitant decrease in neutrophil viability of 51%. 
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As discussed earlier, the metabolic profile of periparturient dairy cows also 
includes high circulating concentrations of ketone bodies. To test the hypothesis that this 
increase in ketones is partially responsible for immunosuppression, Suriyasathaporn et al. 
(1999) compared the chemotaxis ability of lymphocytes isolated from cows between their 
5-10 weeks of lactation with low, medium or high plasma levels of β-hydroxybutyrate 
(BHB). Cows with high levels of BHB (>1.6mM) had a lower chemotactic activity 
compared to those with low and medium BHB levels (<0.8 and 0.8-1.6 mM, 
respectively). Consistently, when they isolated blood lymphocytes from subclinically and 
clinically ketotic cows and incubated them with BHBA, acetoacetate, acetone or a 
mixture of these, they reported an impairment of in-vitro migration ability in an 
environment with ketone bodies. Similarly, 1 and 2.5 mM  concentrations of β-
hydroxybutyric acid in vitro have been shown to inhibit the chemiluminescence 
associated respiratory burst (10 and 15%, respectively) of neutrophils isolated from 
healthy periparturient cows (Hoeben et al., 1997). 
In addition to metabolites, endocrine factors seem to be partially responsible for 
the diminished neutrophil activity during the periparturient period. For example, 
glucocorticosteroids, widely used as anti-inflammatory agents, suppress several functions 
of immunity. Hoeben et al (1998) measured the respiratory burst activity of bovine 
neutrophils in-vitro after exposure to one of eight glucocorticosteroids and reported a 
decrease in the chemiluminescence response from cells treated with 7 out of 8 drugs, 
including cortisone and hydrocortisone which at a concentration of 2 x 10-4 mM reduced 
the respiratory burst activity by 7 and 13%, respectively. However, the peak of cortisol 
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that occurs at calving lasts only hours and might not explain the prolonged state of 
immunosupression observed around (especially prior to) parturition (Overton and 
Waldron, 2004). 
Lactogenic hormones and factors associated with structural and functional 
changes during the dry period and onset of lactation have been related to periods of 
highest incidence of infections (Vangroenweghe et al., 2005). In fact, the effect of the 
lactogenic hormone prolactin (PRL) and growth hormone (GH), both necessary for the 
transition from a proliferative to a lactating mammary gland, on periparturient immunity 
have been studied. Dairy steers on long day photoperiods have higher concentrations of 
circulating PRL but reduced expression of PRL receptor on peripheral blood 
mononuclear cells (PBMCs), compared to those under short day photoperiod exposure 
(Auchtung and Dahl, 2004) and neutrophils collected from cows assigned to a short day 
photoperiod of 8 hours of light during the dry period had greater migration towards the 
chemoattractants IL-8 and C5a, while their lymphocytes showed enhanced cellular 
proliferation (Auchtung et al., 2004). Treatment of cows with bovine somatotropin (bST) 
may enhance neutrophil function; Hoeben et al. (1999) treated healthy lactating cows (6-
15 weeks postpartum) with 500 mg of bST 7 days before and after experimental S. uberis 
infection and reported reduced fever, tachycardia, swelling, pain and firmness of infected 
glands but little effect on the luminol-dependent luminescence of blood neutrophils 
compared to control cows. In summary, all the metabolic and endocrine changes during 
this period seem to contribute to some extent to the reduction in neutrophil function. 
Insulin, a key endocrine regulator of these changes might have an effect on immunity 
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either by altering plasma and tissue concentrations of metabolites and other hormones or 
by a direct effect on PMNs. 
Effect of insulin on neutrophil activity 
Insulin receptors have been detected in low levels on neutrophils in dairy cattle by 
indirect immunofluorescence staining and flow cytometry (Nielsen et al., 2003), but the 
effects of insulin on immune function have not been investigated in dairy cows. It is 
conceivable that insulin could act upon neutrophils in multiple ways. For example, 
changes in insulin concentration or resistance to the hormone might result in a lack of 
stored glycogen within the neutrophil that could limit the production of NADPH and the 
subsequent bacteriocidal peroxidase activity of these cells (Hammon et al., 2006), 
modulation of the activity of key glycolytic enzymes such as glucose-6-phospate 
dehydrogenase (G6PDH) and phosphofructokinase (PFK) (Alba-Loureiro et al., 2006) or 
could alter neutrophil granulopoiesis and differentiation.  
In humans, it has been recognized that patients with diabetes have impaired 
neutrophil phagocytosis, bactericidal activity, release of lysosomal enzymes and 
production of ROS (Alba-Loureiro et al., 2007, Bilgic et al., 2008). Also, neutrophils 
isolated from the peritoneal cavity of induced diabetic rats had reduced phagocytosis and 
hydrogen peroxide content (17 and 31%, respectively) compared to control rats. 
Interestingly, insulin treatment restored these neutrophil functions to the values found in 
control animals (Alba-Loureiro et al., 2006). In view of these findings, the therapeutic 
use of insulin to improve neutrophil function has been further investigated, at least in 
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humans. For example, incubation of neutrophils with insulin at physiologically relevant 
concentrations has been shown to increase their chemotaxis ability in a dose-response 
manner (Cavalot et al., 1992) whereas Rassias et al. (1999) reported that non-diabetic 
patients receiving insulin treatment during cardiac surgery had enhanced phagocytic 
activity due to a 41% increased absolute number of circulating neutrophils.  
Interestingly, infusion of insulin into healthy patients with controlled plasma 
glucose levels has yielded contrasting results. Walrand et al. (2004) infused 0.7 
mU/kg/min of insulin into non-diabetic, non-obese subjects while maintaining strict 
euglycemia for a period of 4 hours. They collected neutrophils from blood before and 
after the infusion and reported that insulin increased the total neutrophil counts by 66%, 
the directed migration of PMNs towards a chemoattractant by approximately 150% as 
well as the overall phagocytosis, and bactericidal capacity, when compared to neutrophils 
isolated before the insulin clamp. Contrary to these results, Fejfarova et al. (2006) 
performed a similar hyperinsulinemic euglycemic clamp on healthy individuals and 
reported no effect of insulin infusion on neutrophil phagocytic or respiratory burst 
activity, compared to neutrophils isolated from subjects receiving a saline infusion. They 
suggested that these findings contrast to those reported by the study of Walrand and 
others (2004) because in that study, the authors did not compare the neutrophil function 




Dairy cows are more susceptible to mastitis during the periparturient period 
because of the development of a state of immunosuppression characterized by a reduction 
of number and function of neutrophils around the time of calving. The mechanisms 
responsible for this decrease in neutrophil function are not completely understood, but it 
is possible that several factors contribute to this phenomenon. Remarkably, the 
periparturient cow experiences a tremendous metabolic challenge due to the increased 
nutrient requirements to support pregnancy and lactogenesis. Thus, the animal undergoes 
a series of physiological changes carefully coordinated by the endocrine system that 
result in partitioning of nutrients towards the mammary gland. In view of this time-
coincidence between the periparturient metabolic changes and this period of 
immunosuppression, the effect of several metabolites and hormones on immune function 
has been investigated. For example, the presence of the mammary gland (Kimura et al., 
1999), the negative energy balance during the periparturient period (Perkins et al., 2002, 
Perkins et al., 2001), high levels of NEFA and ketone bodies (Hoeben et al., 1997, Scalia 
et al., 2006, Suriyasathaporn et al., 2000), cortisol (Hoeben et al., 1998) and sex steroids 
(Winters et al., 2003) have been proposed to contribute to the reduction in the immune 
capacity of transition cows. Despite these considerable efforts, the physiology of the 
periparturient immunosuppression has not been elucidated (Paape et al., 2002b).  
Part of the homeorhetic control in cows during the transition period includes a 
decrease in the plasma concentration of insulin and the development of insulin resistance 
beginning several weeks before parturition that allows a shift from anabolism to 
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catabolism typical of the periparturient period. However, whether insulin modulates 
immune function in dairy cows is unknown. In humans, diabetes has been associated with 
decreased neutrophil function and there is some evidence that exogenous insulin can 
improve this condition. Furthermore, a class of antidiabetic drugs known as 
thiazolidinediones exert insulin-sensitizing effects by binding to the nuclear receptor 
PPARγ. Interestingly, recent studies have reported a potent anti-inflammatory effect of 
these TZDs, at least on human macrophages and peripheral mononuclear cells. Together, 
these findings highlight the potential for therapeutic intervention on insulin metabolism 
of bovine neutrophils to improve the immune competence of dairy cows during the 
periparturient period. 
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CHAPTER TWO: EFFECTS OF IN VITRO INSULIN AND 2,4-
THIAZOLIDINEDIONE ON THE FUNCTION OF NEUTROPHILS 
HARVESTED FROM BLOOD OF COWS IN DIFFERENT PHYSIOLOGICAL 
STATES 
ABSTRACT 
Neutrophils (PMN) were isolated from twenty six Holstein cows in different 
physiological states (12 ± 1.7 d prepartum, n = 8; 7 d postpartum, n = 9; 253 ± 25.2 d 
postpartum, n = 9) and incubated in vitro for 120 min in a factorial arrangement of 
treatments with 0, 1.5 or 15 ng/mL of bovine insulin and 0 or 300 µg/mL of the PPAR-γ 
ligand 2,4-thiazolidinedione (TZD). Following the incubations, PMN functional assays 
were performed to determine treatment effects on total, extracellular, and intracellular 
generation of reactive oxygen species (ROS), neutrophil extracellular trap (NETs) 
formation and phagocytic-killing abilities. The respiratory burst activity of PMN 
collected from cows at 7d postpartum was reduced compared to that of PMN from 
midlactating and pre-partum cows, but NETs expression was 23 and 36% higher in PMN 
from pre-partum cows compared to mid-lactating and post-partum cows, respectively. 
Furthermore, insulin had no effect on any of the assays used to assess PMN function. In 
contrast, TZD inhibited total ROS production by ~89%, increased extracellular 
superoxide generation by ~43% but had no effect on intracellular ROS. Interestingly, 
TZD did not alter the ability of the PMN to release NETs and engulf or kill S. aureus. 
These findings suggest an anti-inflammatory effect of TZD that may result in reduced 
extracellular oxidative damage with maintainance of PMN antimicrobial activity. 




The periparturient dairy cow is more susceptible to infectious diseases in part due 
to a period of immunosuppression that occurs for several weeks around the time of 
calving (Mallard et al., 1998). As an example, the number of first cases of clinical 
mastitis is higher during the first week of lactation compared to those detected from the 
second week onward (Wilson et al., 2004). Also, Shuster et al. (1996) challenged 
periparturient cows with an intramammary infusion of E. coli and reported that they had 
more severe clinical signs of mastitis as well as a more rapid bacterial growth after 10 
hours of inoculation compared to midlactating animals. Despite considerable progress in 
the understanding of the biology of the periparturient cow in the last 25 years, the 
incidence and severity of the most important infectious disease has remained unchanged 
(LeBlanc et al., 2006b). A recent survey by the National Animal Animal Health 
Monitoring Service reported that clinical mastitis is prevalent in 16.5% of the cows in the 
U.S. and that from the total number of cows that are permanently removed from the herd, 
23% are because of mastitis or udder problems (USDA, 2008). 
During an intramammary infection, patrolling macrophages recognize the pathogen 
and trigger an inflammatory response resulting in the migration of polymorphonuclear 
cells (PMN) or neutrophils from circulation to the site of infection. Thus, during the early 
stages of the insult, neutrophils are the predominant leukocyte present in the gland 
accounting for up to 91% of the total leukocyte population (Saad and Ostensson, 1990). 
Neutrophils play a key role in the resolution of mastitis and have been the focus of 
intense research (Paape et al., 2003). These PMN, by means of their TLR receptors and 
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other pattern recognition receptors, bind and engulf opsonized bacteria in a process 
known as phagocytosis. Subsequently, PMN use several killing mechanisms such as 
generation and release of potent oxidants (e.g. intracellular and extracellular release of 
reactive oxygen species or ROS) and antimicrobial enzymes and peptides (Paape et al., 
2002). Neutrophils are also capable of mixing these toxic compounds with their own 
DNA and histones and release these structures termed neutrophil extracellular traps 
(NETs) into the extracellular matrix where the pathogens are physically trapped and 
destroyed (Brinkmann et al., 2004).   
The total number and function of neutrophils are reduced during the periparturient 
period (Cai et al., 1994, Detilleux et al., 1995, Kehrli et al., 1989), but the physiological 
mechanisms responsible for these decreases remain unclear (Paape et al., 2002). 
Remarkably, there is a co-incidence between this period of reduced neutrophil function 
and the periparturient fall of plasma insulin together with the occurrence of insulin 
resistance, typical of lactation (Bell and Bauman, 1997). Moreover, there is evidence that 
insulin can regulate neutrophil function in humans. For instance, neutrophils collected 
from healthy individuals had improved chemotaxis, phagocytosis and bactericidal ability 
after the subjects received a 4-hour insulin infusion under strict euglycemia, relative to 
the neutrophils collected before the infusion (Walrand et al., 2004). However, the effects 
of this hormone on neutrophil function has not been investigated in dairy cows, despite 
the fact that neutrophils isolated from dairy heifers express insulin receptors (Nielsen et 
al., 2003). Furthermore, 2,4 thiazolidinedione (TZD), a synthetic PPARγ ligand, has been 
shown to restore insulin response in steers with insulin resistance induced by recombinant 
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tumor necrosis alpha (Kushibiki et al., 2001). PPARγ is a member of the nuclear receptor 
family highly expressed in adipose tissue and immune system that upon activation can 
regulate adipocyte differentiation, stimulation of insulin action, regulation of lipid 
metabolism and inflammatory processes (Houseknecht et al., 2002). Therefore, we 
hypothesized that periparturient cows have reduced neutrophil function compared to 
midlactating animals and that incubation of PMN with insulin or the PPAR-γ ligand TZD 
would improve PMN functionality as assessed by the production and release of ROS, 
NETs formation, and their phagocytotic and killing ability. 
MATERIALS AND METHODS 
Animal Procedures 
The use and care of all animals were approved by The University of Vermont 
Animal Care and Use Committee. Twenty-six multiparous Holstein cows entering second 
or greater lactation were used in this experiment. All cows were free of obvious clinical 
infection or inflammation and their rectal temperatures were less than 39.5°C. Individual 
milk samples were collected the day of the experiments and somatic cell counts (SCCs) 
were determined using a DeLaval® cell counter (DeLaval International AB, Sweden). 
SCCs were not different between midlactation and postpartum cows (181 ± 54  and 145 ± 
57 x 103 SCC/mL, respectively; P > 0.20). Blood (80 mL) was collected via coccygeal 
vessel puncture into evacuated tubes containing acid-citrate dextrose (Vacutainer®, 
Becton Dickinson, Franklin Lakes, NJ), inverted 3 times and stored on ice until 
laboratory processing (<45 min). Samples were taken from cows 12 ± 1.7 days before 
calving (n=8), 7 days postpartum (n=9) and during mid-lactation (n=9; 253 ± 25.2 days 
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postpartum) to evaluate the differential effects of physiologic state and/or in vitro insulin 
and TZD incubation on blood neutrophil function.  
Reagents 
Percoll® was obtained from GE Healthcare Bio-Sciences Corp. (Piscataway, NJ). 
Bovine insulin at a concentration of 10mg/ml in a 25 mM HEPES, pH 8.2 solution and 
Ionomycin from Streptomyces conglobatus were obtained from Sigma Chemical Co. (St. 
Louis, MO). The 2,4-Thiazolinedione (TZD; Sigma Chemical Co.) was prepared as a 100 
mg/mL stock solution in dimethyl sulfoxide (DMSO). Luminol (5-amino-2,3-dihydro-
1,4-phthalazinedione; Sigma Chemical Co.), methyl cypridina luciferin analog [MCLA; 
2-methyl-6-(4-methoxyphenyl)-3,7dihydroimidazol[1,2-a]pyrazin-3-one hydrochloride; 
Sigma Chemical Co.] and Phorbol 12-myristate,13-acetate (PMA; Sigma Chemical Co.) 
were prepared as 89.4 mM, 1371.1 μM and 162.12 μM stock solutions, respectively, in 
DMSO. 5-(6)-chloromethyl-2',7'-dichlorodihydrofluorescein di-acetate acetyl ester (CM-
H2DCFDA; Invitrogen Co., Eugene, OR) was prepared as 1730.7 μM stock solution in 
DMSO. Sytox® Orange nucleic acid stain was obtained from Invitrogen Co. as a 5 mM 
solution in DMSO. All stock solutions were stored at -20°C. All working solutions and 
cell suspensions were prepared using sterile calcium and magnesium-free Hanks’ 
Balanced Salt Solution (CMF-HBSS; Sigma Chemical Co.) or RPMI-1640 (GIBCO, 




Isolation of Bovine Neutrophils  
Neutrophils were isolated using procedures modified from Weber et al. (2001) as 
validated in our laboratory. Blood (10 mL) was aliquotted into to 50-mL polypropylene 
conical tubes (Corning Inc., NY) and centrifuged at 1000 × g for 20 min at 4°C to 
separate plasma from the cell pack. Plasma was discarded and the remaining cells were 
suspended in 35 mL of ice-cold PBS. The suspension was gently pipetted down the side 
of a 50-mL polypropylene conical tube containing 10 mL of 1.084 g/mL of Percoll®. The 
cells were then subjected to gradient centrifugation (400 x g for 40 min at 22°C). The 
supernatant, mononuclear cell layer and Percoll® were aseptically aspirated and 
discarded.  The pellet (PMN and erythrocytes) was retained and erythrocytes were lysed 
by hypotonic shock.  For this procedure, 2 volumes of an ice-cold 10.56 mM Na2HPO4, 
2.67 mM NaH2PO4 solution were added to 1 volume of cell suspension and the solution 
was mixed by gentle aspiration and inversion. Tonicity was restored by the addition of 1 
volume of a 10.56 mM Na2HPO4, 2.67 mM NaH2PO4 0.43 M NaCl solution. The cell 
solution was then centrifuged (500 x g) for 4 min at 4°C and the pellet washed twice by 
resuspension in 35 mL of CMF-HBSS (Sigma Chemical Co.) and recentrifugation (500 x 
g for 3 min at 4°C). Cell viability and differential cell counts were determined using light 
microscopy by Trypan Blue (Sigma Chemical Co.) exclusion and Giemsa stained smears, 
respectively. Purity of PMN was > 95% and viability > 97%. Cells were suspended either 
in CMF-HBSS or RPMI-1640, the concentration of cells was adjusted for every assay 
and the suspensions were kept at 4 °C until use in functional assays.  
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Insulin and TZD Incubations  
Incubations and functional assays were performed in white-walled, clear-bottomed 
96-well microplates (Corning, Costar Inc., NY), except for the killing-phagocytosis assay 
which was conducted in 5 mL polystyrene round-bottomed tubes (Becton Dickinson 
Labware, Franklin Lakes, NJ). For all the assays, working solutions of insulin and/or 
TZD in CMF-HBSS or RPMI-1640 + 2% heat-inactivated FBS (NETs assay) were 
pipetted into the wells or tubes to reach final concentrations of 0, 1.5 or 15 ng/mL of 
insulin with 300 µg/mL of TZD either alone or in combination with the insulin 
treatments. Suspensions of 2 x 105 (Luminol assay; final volume 200 µL/well), 4 x 105 
(MCLA and CM-H2DCFDA assays; final volume 150 µL/well), 5 x 105 (NETs assay; 
final volume 100 µL/well) and 2 x 105 neutrophils (killing-phagocytosis assay; final 
volume 1000 µL/tube) in CMF-HBSS or RPMI 1640 were added to the treatment 
solutions. The plates and tubes were then incubated with lids in a humidified incubator 
(37°C, 5% CO2) for 120 minutes while gently shaking. After incubation, the cell 
suspensions were mixed by aspiration and the functional assays performed. 
Luminol Chemiluminescence Assay 
After incubation with insulin and TZD, the total neutrophil ROS production was 
immediately assessed by a luminol chemiluminescence assay as described by Rinaldi et 
al. (2006b) with some modifications. Luminol is a cell permeable compound that reacts 
with several ROS including superoxide (O2-), hydroxyl radical (OH-), hydrogen peroxide 
(H2O2), peroxynitrite (ONOO-) and hypochlorous acid (HClO); thus, the derived 
luminescence product of these reactions in the presence of luminol is an indicator of 
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intracellular and extracellular ROS produced by PMN (Rinaldi et al., 2006b). Twenty 
microliters of 5mM 5-amino-2,3-dihydro-1,4-phthalazinedione (Luminol) and 20 µL of 
either 400 nM PMA (stimulated cells) or HBSS (control) were added to all wells. All 
reactions were then adjusted to 200 uL using CMF-HBSS. Chemiluminescence (CL) was 
measured every 5 or 10 min for 190 min with a Synergy HT plate reader (BioTek 
Instruments, Inc., Winooski, VT). All reactions were carried out in quadruplicates. 
Background values, defined as the mean CL values of unactivated PMN, were subtracted 
from all readings. 
MCLA Chemiluminescence Assay  
After incubation, the extracellular neutrophil superoxide anion radical (O2-) 
production was measured by a MCLA chemiluminescence assay. The specificity of this 
probe for O2- has been confirmed by total inhibition by superoxide dismutase which 
catalyzes the conversion of O2- to H2O2 (Rinaldi et al., 2006b). Ten microliters of 2 µM 
MCLA and 30 µL of either 400 nM PMA (stimulated cells) or HBSS (control) were 
added to all wells. The reactions were then adjusted to a volume of 200 uL using CMF-
HBSS. The CL was measured every 10 min for 80 min with a Synergy HT plate reader 
(BioTek Instruments, Inc., Winooski, VT). Since MCLA is rapidly consumed, 10 µL of 2 
µM MCLA were added to each well immediately before each 10-min reading throughout 
the course of CL measurements. All reactions were carried out in quintuplicates. 
Background values, defined as the mean CL values of unactivated PMN, were subtracted 
from all readings. 
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CM-H2DCFDA Fluorescence Assay 
The intracellular neutrophil ROS production was assessed a the CM-H2DCFDA 
fluorescence assay with some modifications. CM-H2DCFDA is a cell-permeant probe 
that reacts only with ROS that are trapped inside the cell, including hydrogen peroxide 
(H2O2), nitric oxide (NO) and peroxynitrite anion (ONOO-) (Rinaldi et al., 2006b). After 
incubation, 10 µL of 200 µM CM-H2DCFDA and 30 µL of either 400 nM PMA 
(stimulated cells) or HBSS (control) were added to all wells. All reactions were then 
adjusted to 200 uL using CMF-HBSS. Fluorescence was measured every 10 min for 200 
min, except between min 30 and 70 when it was measured every 5 min, with a Synergy 
HT plate reader (BioTek Instruments, Inc., Winooski, VT) at an excitation wavelength of 
485 nm and an emission wavelength of 528 nm. All reactions were carried out in 
quadruplicates. Background values, defined as the mean fluorescence values of 
unactivated PMN, were subtracted from all readings. 
Neutrophil Extracellular Trap (NETs) Assay 
Neutrophil extracellular trap formation was quantified using Sytox® Orange as 
described by Lippolis et al. (2006b) with some modifications. After PMN incubation with 
treatments in 96-well plates for 120 min, 20 uL of PMA and 20 uL of ionomycin were 
added to the stimulated set of wells to obtain a final concentration of 10 ng/ml and 1 μM, 
respectively. Forty microliters of RPMI-1640 + 2% heat-inactivated FBS were added to 
the control wells. Subsequently, the plates were centrifuged (10 min at 650 × g) and 
incubated (37 °C and 5% CO2 for 60 min). After incubation, supernatant from the plates 
was removed, and the wells were stained and protected from light with 50 μl of 5 μM 
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Sytox Orange in CMF-HBSS (10 min at room temperature). The stain was poured off, 
and the wells washed once with 100 μl of CMF-HBSS. All reactions were performed in 
sixtuplicates. A Synergy HT plate reader (BioTek Instruments, Inc) was used to detect 
fluorescence with an excitation wavelength of 530 nm and emission wavelength of 580 
nm.  
Killing and Phagocytosis Assay 
The assay was performed as described by Rinaldi et al. (2006a) with modifications.  
Staphylococcus aureus strain 305 (American Type Culture Collection, Manassas, VA) 
was inoculated on a blood agar plate (Northeast Laboratory Services Inc., ME) and 
incubated overnight at 37°C. Ten colonies were transferred from the plate to a sterile tube 
containing 10 mL of brain–heart infusion broth (Becton Dickinson Diagnostic Systems, 
Inc.) and incubated overnight at 37°C at 225 rpm in an orbital shaker. After the overnight 
incubation, the tube was placed in an ice-water bath and mixed using a vortex mixer. One 
hundred microliters from the culture were serially diluted in PBS and 100 μL of the 
resulting dilutions were spread on blood agar plates. The plates were incubated overnight 
at 37°C and the stock culture maintained at 4°C. After determining the concentration 
[colony forming units (cfu)/mL] of the stock culture based on the colony counts of the 
spread plates, the stock culture was diluted in HBSS to yield a final concentration of 4 x 
107 cfu/mL. 
To assess PMN phagocytosis and killing, 200 µL of S. aureus (8 x 106 cfu) were 
added to sterile tubes with or without 2 x 106 neutrophils previously incubated (1.4 mL) 
and 400 µL of pooled, heat-inactivated bovine serum. The ratio of bacteria to neutrophils 
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was 4:1. The samples were placed on an orbital shaker for 60 min at 37°C. All reactions 
were performed in duplicate. To determine the percentage of PMN containing 
phagocytosed bacteria and the actual number of phagocytosed bacteria per PMN, a 50-µL 
aliquot of each reaction was used to prepare a smear that was stained with Giemsa stain. 
The first 100 PMN encountered in the field of view of a light microscope were scored as 
either positive or negative for intracellular bacteria. For those PMN scored as positive, 
the number of intracellular bacteria was enumerated. 
To evaluate whether insulin and TZD incubations affected the bactericidal activity 
of PMN, 1.95 mL of the remaining reaction were placed in ice and sonicated with a sonic 
dismembrator (Model 100, Thermo Fisher Scientific Inc.) at a power setting of 1 for 15 s. 
Rupture of the PMN was verified by microscopic examination. Sonication did not affect 
bacterial viability (Rinaldi et al., 2006b; unpublished observation). A 100 μL aliquot 
from each sonicated reaction was serially diluted in PBS and 100 μL quantities of the 
resulting dilutions was spread on blood agar plates. The plates were incubated overnight 
at 37°C and the colonies enumerated. The percentage of bacteria killed were determined 
by calculating the difference in the number of bacteria incubated in the absence and 
presence of PMN and dividing this difference by the number of bacteria incubated in the 
absence of PMN. 
Statistical Analysis 
The experiment was conducted as a completely randomized design with three 
levels of treatment (insulin, TZD and physiological state) applied to the incubation 
well/tube within cow. Data was analyzed by analysis of variance as a mixed model using 
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the mixed procedure of SAS (2001). The variables in the model statement included 
animal, the treatments and their interactions. For the luminol-, MCLA-, and CM-
H2DCFDA-based assays involving multiple measurements of CL or fluorescence over 
time, the area under the curve (AUC) was calculated from plotted data points for each 
experimental condition using the expand procedure of SAS with cubic spline 
interpolation and the trapezoid rule (SAS, 2001). The analyzed area between the curves 
was generated using the least squares estimates for CL or fluorescence at each time point 
in the assay and this area was used as the value tested for analysis of variance. For the 
CM-H2DCFDA assay, a mixed model analysis of variance with repeated measures was 
also used as a more sensitive analysis of treatment differences than the calculation of 
AUC. Least squares means and standard errors were generated using the LSMeans 
statement in conjunction with the pdiff option of SAS (2001). Tukey’s multiple 
comparison test was used to assess specific treatment differences for those variables 
shown to have significant overall treatment effects in the analysis of variance. All 
reported means are the adjusted least squares means ± standard error of the mean (SEM) 
and the significance was declared when P < 0.01. 
RESULTS 
Reactive Oxygen Species Production 
Changes in luminol-derived CL were evident 30 min after activation with PMA. For 
those cells incubated with 0, 1.5 or 15 ng/mL of insulin without TZD, CL values peaked 
100 min after activation and then decreased. In contrast, the luminol-derived CL values 
of PMN treated with 300 μg/mL of TZD were only modestly increased from baseline 
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with a peak at 70 min after activation and a much more rapid decline back to baseline 
compared to insulin-only treatments or control wells (Figure 2.1A). To determine any 
differential effects of in vitro insulin and TZD treatment on PMN, the areas under the 
curve (AUCs) were calculated from these plotted data points. Insulin treatment had no 
effect on the luminol-dependant CL associated with total ROS production in PMA-
stimulated cells as luminol-derived CL was not different between control and insulin-
only treated wells (Figure 2.1B; insulin treatment effect, P > 0.20). Incubation of cells 
with 300 μg/mL of TZD inhibited total ROS by approximately 88.9%, compared to 
control and insulin-only treated wells (Figure 2.1B; TZD treatment effect, P < 0.01). The 
overall effect of physiological state on luminol-derived CL is presented in Figure 2.2. The 
luminol-derived CL of neutrophils isolated from postpartum cows was 37 and 32% lower 
compared to midlactation and prepartum animals, respectively (physiological state effect, 
P < 0.01). However, the luminol-derived CL of PMN collected from midlactation was 
similar to that of PMN isolated from prepartum cows (midlactation vs. prepartum, P > 
0.20). Furthermore, there was no insulin by physiological state interaction effect (P > 
0.20), but the magnitude of the reduction in the luminol-derived CL observed in 
postpartum cows relative to midlactation and prepartum cows with 0 μg/mL TZD 
treatment was lower than the magnitude of this reduction in PMN incubated with 300 
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Figure 2.1 Effect of Insulin (INS) and 2,4-Thiazolinedione (TZD) on total ROS 
production by bovine neutrophils. 
Neutrophils were collected from cows (n = 25) and incubated with 0, 1.5 or 15 ng/mL of 
insulin and 0 or 300 µg/mL of TZD either alone or in combination with the insulin 
treatments. Data represent the mean luminol-derived chemiluminescence (CL) in 
arbitrary units measured every 5 or 10 min over a 190 min period after activation of 
neutrophils with Phorbol 12-myristate,13-acetate (PMA). The CL values of non-activated 
neutrophils were substracted from all the CL measurements at every time point (A). To 
assess the overall magnitude of the luminol-dependant CL response over time, the area 
under the curve (± SEM) calculated from plotted luminol-derived measurements (B). ** 

































Figure 2.2 Effect of physiological state on total ROS production by bovine neutrophils.  
Neutrophils were collected from pregnant midlactation (253 ± 25.2 d postpartum; n = 9), 
prepartum (-12 ± 1.7 d; n = 8) and postpartum (+7d; n = 8) cows. Data represent the area 
under the curve (± SEM) calculated from plotted luminol-derived measurements over a 
190 min period after activation of neutrophils with Phorbol 12-myristate,13-acetate 
(PMA). The CL values of non-activated neutrophils were substracted from all the CL 
measurements at every time point. **Physiological state effect, P < 0.01. a,b Bars with 
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Figure 2.3 Effects of TZD and physiological state on total ROS production by bovine 
neutrophils.  
Neutrophils were collected from pregnant midlactation (253 ± 25.2 d postpartum; n = 9), 
prepartum (-12 ± 1.7 d; n = 8) and postpartum (+7d; n = 8) cows. Data represent the area 
under the curve (± SEM) calculated from plotted luminol-derived measurements over a 
190 min period after activation of neutrophils with Phorbol 12-myristate,13-acetate 
(PMA). The CL values of non-activated neutrophils were substracted from all the CL 
measurements at every time point. **TZD by physiological state effect, P < 0.01. a,b,c 
Bars with different letters differ (P < 0.01). 
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The MCLA-derived CL in all treatment and control groups peaked at the 21 min 
measurement time-point after PMA activation and then declined. The PMN treated with 
300 μg/mL of TZD had a higher maximal response after cell stimulation and this 
difference was maintained throughout the rest of CL measurements, compared to insulin-
only treatments or control wells (Figure 2.4A). To determine any differential effects of in 
vitro insulin and TZD treatment on PMN, the areas under the curve (AUCs) were 
calculated from these plotted data points. Insulin treatment had no effect relative to 
control wells on the MCLA-dependant CL associated with extracellular O2- ROS 
production in PMA-stimulated cells (Figure 2.4B; insulin treatment effect, P > 0.20). In 
contrast, TZD enhanced the O2- generation in approximately 43% compared to control 
wells (Figure 2.4B; TZD treatment effect, P < 0.01). Neutrophils from postpartum cows 
had a 43 and 37% lower MCLA-dependant CL, compared to midlactating and prepartum 
animals, respectively (Figure 2.5; physiological state effect, P < 0.01). The MCLA-
derived CL of PMN collected from midlactating was similar to that of PMN isolated from 
prepartum cows (Figure 2.5; P > 0.20). No interaction effects with either in vitro 
treatment or physiological state were evident for PMN MCLA-derived CL (all 
interactions, P > 0.20).  
Changes in CM-H2DCFDA-derived fluorescence were observed after 30 min after 
activation with PMA. The fluorescence values from the cells incubated with 300 μ/mL of 
TZD increased and reached a plateau approximately 140 min after stimulation whereas 
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Figure 2.4 Effect of Insulin (INS) and 2,4-Thiazolinedione (TZD) on extracellular O2- 
production by bovine neutrophils.  
Neutrophils were collected from cows (n = 26) and incubated with 0, 1.5 or 15 ng/mL of 
insulin and 0 or 300 µg/mL of TZD either alone or in combination with the insulin 
treatments. (A) Mean MCLA-dependant chemiluminescence (CL) (arbitrary units) 
measured every 10 min over a 80 min period after activation of neutrophils with Phorbol 
12-myristate,13-acetate (PMA). The CL values of non-activated neutrophils were 
substracted from all the CL measurements at every time point (A). To assess the overall 
magnitude of the luminol-dependant CL response over time, the area under the curve (± 
SEM) calculated from plotted luminol-derived measurements (B). ** TZD treatment 
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Figure 2.5 Effect of physiological state on extracellular O2- production by bovine 
neutrophils.  
Neutrophils were collected from pregnant midlactation (253 ± 25.2 d postpartum; n = 9), 
prepartum (-12 ± 1.7 d; n = 8) and postpartum (+7d; n = 9) cows. Data represent the area 
under the curve (± SEM) calculated from plotted MCLA-derived measurements over a 70 
min period after activation of neutrophils with Phorbol 12-myristate,13-acetate (PMA). 
The CL values of non-activated neutrophils were substracted from all the CL 
measurements at every time point. **Physiological state effect, P < 0.01. a,b Bars with 
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Figure 2.6 Effect of Insulin (INS) and 2,4-Thiazolinedione (TZD) on intracellular ROS 
production by bovine neutrophils. 
Neutrophils were collected from cows (n = 24) and incubated with 0, 1.5 or 15 ng/mL of 
insulin and 0 or 300 µg/mL of TZD. Data represent the mean CM-H2DCFDA-derived 
fluorescence in arbitrary units measured every 10 min over a 200 min period after 
activation of neutrophils with Phorbol 12-myristate,13-acetate (PMA). The fluorescence 
values of non-activated neutrophils were substracted from all measurements at every time 
point. **TZD by incubation time relative to PMA activation effect, P < 0.01.  (A). To 
assess the overall magnitude of the CM-H2DCFDA-derived fluorescence response over 
time, the area under the curve (± SEM) was calculated from plotted measurements (B). 
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There was no effect of insulin or TZD on the intracellular ROS production based 
on calculated AUCs (Figure 2.6B; insulin or TZD effect, P > 0.20). However, when the 
data were analyzed by analysis of variance with repeated measures for each incubation 
measurement time-point, the interaction of TZD by incubation time relative to PMA 
activation was significant (Figure 2.6A; P < 0.01). Furthermore, the intracellular ROS 
production of neutrophils isolated from postpartum cows was 43 and 37% lower, 
compared to midlactation and prepartum animals, respectively (Figure 2.7; physiological 
state effect, P < 0.01). However, the fluorescence values of PMN collected from 
midlactation was similar to that of PMN isolated from prepartum cows (Figure 2.7; P > 
0.20). There were no insulin by TZD or in vitro treatment by physiological state 
interaction effects on the PMN intracellular generation of ROS as measured by CM-
H2DCFDA-derived fluorescence (all interactions, P > 0.20). 
Neutrophil Extracellular Trap Release (NETs) 
There was no effect of insulin or TZD on NETs release relative to control wells 
(Figure 2.8; effect of insulin or TZD, P > 0.20). However, the mean fluorescence 
associated with NETs released from neutrophils collected from prepartum cows was 23 
and 36% higher than that of PMN collected from midlactating and postpartum cows, 
respectively (Figure 2.9; day of lactation effect, P < 0.01).  Neutrophil NETs expression 
from midlactation cows was similar to that of PMN isolated from postpartum cows 
(Figure 2.9; P > 0.20). There were no insulin by TZD or in vitro treatment by 















































Figure 2.7 Effect of physiological state on intracellular ROS production measured by 
bovine neutrophil. 
Neutrophils were collected from pregnant midlactation (253 ± 25.2 d postpartum; n = 9), 
prepartum (-12.7 d; n = 8) and post-partum (+7d; n = 7) cows. Data represent the area 
under the curve (± SEM) calculated from plotted CM-H2DCFDA-derived measurements 
over a 200 min period after activation of neutrophils with Phorbol 12-myristate,13-
acetate (PMA). The CL values of non-activated neutrophils were substracted from all the 
CL measurements at every time point. **Physiological state effect, P < 0.01. a,b Bars with 
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Figure 2.8 Effect of Insulin (INS) and 2,4-Thiazolinedione (TZD) on NETs expression by 
bovine neutrophils.  
Neutrophils were collected from cows (n = 24) and incubated with 0, 1.5 or 15 ng/mL of 
insulin and 0 or 300 µg/mL of TZD. Data represent the mean fluorescence in arbitrary 







































Figure 2.9 Effect of physiologcal state on NETs expression by bovine neutrophils.  
PMN were collected from pregnant midlactation (253 ± 25.2 d postpartum; n = 8), 
prepartum (-12 ± 1.7 d; n = 8) and postpartum (+7d; n = 8) cows. Data represents mean 
fluorescence (± SEM) of cells stained with Sytox Orange after 1-hour incubation with 
Phorbol 12-myristate,13-acetate (PMA). **Physiological state effect, P < 0.01. a,b Bars 
with different letters differ (P < 0.01). 
65 
 
Killing and Phagocytosis 
There was no effect of insulin or TZD or their combination on the percentage of 
cells positive for intracellular bacteria or the number of phagocytosed S. aureus per PMN 
(Table 2.1; insulin or TZD effect, P > 0.20). Neutrophils collected from postpartum cows 
had higher percentage of cells with phagocytosed bacteria and number of bacteria per 
neutrophil, compared to prepartum and midlactation animals (Table 2.2; physiological 
state effect, P < 0.01). There was no effect of insulin or TZD on the killing ability of 
PMN (Table 2.1; insulin or TZD effect, P > 0.20). However, the killing ability of 
neutrophils isolated from postpartum animals was 61 and 97% higher compared to 
prepartum and midlactation animals, respectively (Table 2.2; physiological state effect, P 
< 0.01).  No in vitro treatment or physiological sate interaction effects were evident (all 







Table 2.1 Effect of insulin (INS) and 2,4-Thiazolinedione (TZD) on the bactericidal and 
phagocytic abilities of neutrophils against Staphylococcus aureus* 
Treatment (ng/mL INS + μg/mL TZD) 
Index 
0 + 0 1.5 + 0 15 + 0 0 + 300 1.5 + 300 15 + 300 
PMN with phagocytosed 
bacteria, % 27.3 ± 4 26.0 ± 4 25.5 ± 4 23.7 ± 4 24.1 ± 4 23.4 ± 4 
Number of engulfed 
bacteria per PMN 13.0 ± 1 13.4 ± 1 12.3 ± 1 12.6 ± 1 12.9 ± 1 12.4 ± 1 
Killing ability, % 23.3 ± 4 24.8 ± 4 23.7 ± 4 22.7 ± 4 21.7 ± 4 20.5 ± 4 
 







Table 2.2 Effect of physiological state on the bactericidal and phagocytic abilities of 
neutrophils against Staphylococcus aureus* 
Index Mid-lactation Pre-partum Post-partum
PMN with phagocytosed bacteria, % 13.1 ± 2.8a 21.7 ± 2.8
a 40.2 ± 2.8b 
Number of engulfed bacteria per PMN 11.5 ± 0.6a 11.4 ± 0.6a 15.4 ± 0.6b 
Killing ability, % 16.3 ± 2.6a 19.9 ± 2.7a 32.1 ± 2.7b 
 
*Data are means (± SEM; n=8) Effect of physiological state, P < 0.01 
 




The total, intracellular and extracellular ROS production of blood neutrophils 
collected from prepartum and postpartum cows was reduced compared to that of PMN 
isolated from midlactation animals although the difference between prepartum and 
postpartum cows was not significant. These results are in concordance with previous 
reports  (Dosogne et al., 1999, Hoeben et al., 2000, Mehrzad et al., 2001, 2002). 
However, there are conflicting reports regarding the changes in ROS generation between 
the prepartum and early lactation period. For instance, Hoeben et al. (2000) and Dosogne 
et al. (1999) reported a reduction in luminol-dependant CL beginning ~3 weeks before 
parturition with minimum levels 1 week after calving, but only the second group reported 
a significant decrease in PMA-induced CL of neutrophils between -1 and 1 week after 
parturition. Furthermore, this reduction in the capacity of the PMN to produce ROS can 
be partially explained by the decrease in the protein abundance (Lippolis et al., 2006a) 
and activity (Cai et al., 1994) of the enzyme myeloperoxidase reported in early lactation. 
The results of the current study confirm that the respiratory burst activity of blood 
neutrophils from cows in early lactation, independently of the cellular location of ROS, is 
impaired and perhaps contributes to the period of high incidence and severity of 
infectious diseases that cows experience around the time of calving (Mallard et al., 1998, 
Vangroenweghe et al., 2005).  
PMN from prepartum cows expressed higher levels of NETs compared to mid and 
early lactation animals. Contrary to the oxygen-dependent killing mechanisms, NETs 
may not experience a period of reduced functionality during the periparturient period. In 
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fact, Lippolis et al. (2006b) reported that incubation of PMN in milk, in contrast with 
other aspects of neutrophil function, did not reduce their ability to release NETs 
suggesting that when other PMN killing mechanisms are impaired, neutrophils might rely 
on the antimicrobial activity of NETs. The same group (2006a), performed a proteomic 
analysis of bovine PMN collected during midlactation and 28 days before calving and 
reported that those from prepartum cows, had higher levels of the histones H2B.e and 
H2B.f. Because these histones are structural components of NETs  (Brinkmann et al., 
2004), their enhanced expression may contribute to the increased NETs synthesis in 
prepartum vs. midlactating cows observed in our study. 
The phagocytic capacity assessed by the percentage of PMN with engulfed S. 
aureus and the number of intracellular bacteria of neutrophils from early lactation cows 
was increased compared to prepartum and midlactating animals. Increases in neutrophil 
phagocytic activity during the periparturient period have also been reported in several 
studies (Detilleux et al., 1995, Dosogne et al., 1999, Guidry et al., 1976, Kehrli et al., 
1989). This inverse relationship between the neutrophil ROS generation and the 
phagocytic ability during early lactation has been attributed to the ability of the PMN to 
use the extra energy available for phagocytic processes in a period when the consumption 
of energy for production of ROS is reduced (Detilleux et al., 1995). Conversely, Cai et al. 
(1994) and Daniel et al. (1991) reported no change in neutrophil phagocytosis during the 
periparturient period whereas Dosogne et al. (2001) found no difference in phagocytosis 
between PMN collected from midlactation, prepartum and postpartum cows. This 
inconsistency in findings may be attributed to the different pathogens and neutrophil to 
69 
 
pathogen ratio used in the in vitro co-cultures. However, in contrast with other aspects of 
neutrophil function, none of these reports suggest that the phagocytic ability of 
neutrophils is impaired during the periparturient period, suggesting that decreased 
phagocytic ability may not contribute to periparturient immunosuppression. 
In this study, the killing ability of PMN from early lactation cows against S. aureus 
was higher than that of prepartum and midlactation animals. On the other hand, most 
studies that have measured the bactericidal activity of neutrophils during the 
periparturient period have reported a decrease in the overall killing capacity of PMN 
against gram positive and negative bacteria (Cai et al., 1994, Daniel et al., 1991, 
Detilleux et al., 1995, Dosogne et al., 2001, Kehrli et al., 1989). The conflicting results of 
our study may be attributed to the lower 4:1 bacteria to PMN ratio that we used in our co-
culture in an effort to reduce the number of intracellular bacteria and improve light 
microscopy-counting. This might be reflected in the lower killing percentages obtained in 
our assays (~21%), compared to the ~57% reported by Rinaldi et al. (Rinaldi et al., 
2006a) who performed a killing assay under similar conditions, except for a higher 16:1 
bacteria to neutrophil ratio. In fact, Detilleux et al. (2004) applied mathematical models 
that describe the changes in bacteria number during exposure to PMN in vitro and 
determined that the bacteria to neutrophil ratio should be within the range of 12:1 and 
175:1 for effective phagocytosis and killing.  
Incubation of PMN with a high physiological (1.5ng/mL) or a supraphysiologycal 
(15 ng/mL) concentration of insulin had no effect on the respiratory burst activity, NETs 
release, phagocytosis and killing ability of neutrophils isolated from cows in different 
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physiological states. In contrast, experiments with human neutrophils indicate that insulin 
stimulated in a dose-response manner the generation of hydrogen peroxide (Spagnoli et 
al., 1995) and chemotactic ability (Cavalot et al., 1992), whereas 100 µU/mL of insulin 
increased the expression of the neutrophil intercellular adhesion molecule-1 (ICAM-1) by 
approximately 80% (Okouchi et al., 2002). Also, it has been reported that patients with 
diabetes mellitus have increased susceptibility to and severity of infections (Bertoni et al., 
2001), in part as a result of alterations in neutrophil phagocytosis, respiratory burst 
activity and H2O2 production (Alba-Loureiro et al., 2006, Bilgic et al., 2008). Insulin 
treatment improved neutrophil phagocytic capacity of diabetic patients with foot 
infections (Top et al., 2007) and after cardiac surgery (Rassias et al., 1999). However, 
studies looking at the effect of experimental hyperinsulinemia on neutrophil function in 
non-diabetic subjects have yielded conflicting results. For instance, Walrand et al. (2004) 
reported an increase in chemotaxis, phagocytosis and bactericidal activities in PMN 
collected from healthy individuals after a 4-hour hyperinsuliemic euglycemic clamp 
whereas Fejfarova et al. (2006) and Stegenga (2008) did not find any alterations of 
phagocytosis, migration and ROS production during induced hyperinsulinemia with strict 
euglycemia when compared to subjects receiving saline infusion. In summary, there is 
evidence from in vitro and in vivo studies in humans that insulin modulates neutrophil 
functionality, at least in individuals with defective insulinemia. In dairy cows, plasma 
insulin levels and the peripheral tissue sensitivity and responsiveness to insulin is lower 
in the periparturient period compared to midlactation, as part of the homeorhetic 
adaptations that support the increased influx of nutrients towards pregnancy and lactation 
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(Bell and Bauman, 1997). Thus, we hypothesized that in vitro incubation with higher 
insulin levels, alone or in combination with the PPAR-γ agonist and insulin sensitizing 
agent TZD would have a differential effect on the functionality of periparturient PMN, 
relative to PMN isolated from midlactating cows. The lack of a direct effect of insulin on 
bovine neutrophil activity reported in this study may be explained by the low levels of 
insulin receptors detected on bovine neutrophils (Nielsen et al., 2003). Perhaps, in dairy 
cows, insulin does not regulate neutrophil function directly, but might act indirectly via 
improvement of metabolic control during the periparturient period. For instance, insulin 
may reduce the level of circulating non-esterified fatty acids (NEFA) and ketone bodies 
that have detrimental effects on neutrophil and leukocyte activity (Scalia et al., 2006, 
Suriyasathaporn et al., 1999). Thus, the in vivo effect of insulin on periparturient 
neutrophil function requires investigation. 
Incubation of PMN with TZD resulted in a potent inhibitory effect on the 
neutrophil luminol-dependant CL, an indicator of the PMN generation of a wide array of 
ROS including extracellular and intracellular hydroxyl radical (OH-), peroxynitrite 
(ONOO-), hypochlourus acid (HClO), intracellular superoxide (O2-) and hydrogen 
peroxide (H2O2) (Rinaldi et al., 2006b). Furthermore, TZD had no effect on the 
generation of intracellular NO, ONOO- and H2O2 assesed by the CM-H2DCFDA 
fluorescence assay, when the differences were assessed by calculated AUCs. However, 
when the data was analyzed by ANOVA with repeated measures, the effect of TZD 
treatment by incubation time was significant. Perhaps TZD decreases the CM-
H2DCFDA-derived fluorescence of PMN, but the duration of our assay might have not 
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been enough for TZD to affect the generation of intracellular ROS. These findings are 
consistent with the emerging evidence regarding the anti-inflammatory effects of 
thiazolidinediones and other PPAR-γ ligands. Importantly, these effects are thought to be 
mediated by the inhibition of the nuclear factor κB (NFκB), which during inflammation, 
enters the nucleus and activates the expression of several pro-inflammatory genes, 
including cytokines and enzymes necessary for the production of ROS (Karin and Ben-
Neriah, 2000, Rutledge and Adeli, 2007). Indeed, Ghanim et al. (2001) treated obese 
subjects with troglitazone, a insulin sensitizer of the TZD class, and reported a marked 
fall in ROS generation by mononuclear cells together with a decrease in the expression of 
NADPH oxidase, NFκB and IκB proteins. These TZD anti-inflammatory effects might 
be independent of metabolic alterations because administration of a lower dose of a TZD 
to diabetic patients resulted in decreased inflammatory markers without changes in 
glucose homeostasis, plasma insulin and free fatty acids (Ghanim et al., 2006). Since 
excess of ROS production can damage the host cell membrane by peroxidation of the 
components of the lipid bilayer (Fialkow et al., 2007), cause alterations in several 
regulatory pathways that modulate apoptosis (Fadeel et al., 1998), expression of 
cytokines and phagocytosis (Zhang et al., 2003) or ultimately promote injury to the 
surrounding tissue (Capuco et al., 1986), TZD treatment may be beneficial to the dairy 
cow during an inflammatory process by means of reducing the host cell oxidative stress 
or by decreasing the damage that ROS cause to the surrounding tissue. Importantly, the 
reduction of ROS generation by TZD observed in this study was not accompanied by an 
impaired ability of the neutrophils to release NETs or engulf and kill bacteria, suggesting 
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that TZD may reduce inflammation while leaving the essential antimicrobial capacity of 
neutrophils intact. Furthermore, it is conceivable that TZD has different effects on 
individual ROS produced by bovine PMN. The fact that neutrophils incubated with TZD 
had increased concentrations of extracellular O2- measured by MCLA-derived CL can be 
explained by the lower generation of H2O2, OH-, ONOO- and HClO. Since O2- is the main 
precursor of these compounds that result from reactions catalyzed by the enzymes 
superoxide dismutase and myeloperoxidase (Hodgson et al., 2006, Shepherd, 1986), the 
inhibition of these reactions may result in higher concentrations of O2- available for 
dismutation to hydrogen peroxide and oxygen. 
In vivo administration of TZD to periparturient cows might improve their immune 
function directly by reducing the oxidative stress that the immune cells experience 
themselves during the generation of ROS or by decreasing the damage that ROS cause to 
the surrounding tissue during inflammation. These effects can be exerted on neutrophils, 
as reported in our study, or on other leukocytes, as suggested by experiments involving 
human peripheral mononuclear cells (Jiang et al., 1998) and macrophages (Ricote et al., 
1998). Furthermore, in vivo administration of TZD restored the insulin-mediated glucose 
utilization of steers with rbTNF-induced insulin resistance (Kushibiki et al., 2001) and 
infusion of TZD to cows during the last 25 days of pregnancy resulted in a 15% reduction 
of plasma prepartum NEFA concentrations and a decrease of β-hydroxybutyrate (BHBA) 
as parturition approached, compared to control animals (Smith et al., 2007). Thus, it is 
possible that TZD may also improve the immunity of periparturient cows indirectly by 
improving glucose metabolism of leukocytes or by reducing the plasma concentration of 
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NEFA and β-hydroxybutyrate (BHBA) that have been shown to have a negative effect on 
PMN function (Hoeben et al., 1997, Scalia et al., 2006). 
CONCLUSIONS 
As indicated by three assays to measure PMN ROS production, the respiratory 
burst of PMN is impaired in early lactation, and may contribute to the state of 
immunosuppression.  Interestingly, NETs formation was not impaired postpartum and 
was actually increased in prepartum dairy cows. Our results suggest that insulin has no 
direct effect on bovine neutrophil function, but TZD increased the generation of 
intracellular superoxide anion and strongly inhibited the release of other intracellular and 
extracellular ROS. Interestingly, these anti-inflammatory effects of TZD did not interfere 
with the overall neutrophil phagocytosis and killing ability, suggesting that TZD may 
reduce the cell oxidative stress and diminish the damage that ROS cause to the 
surrounding tissue. Furthermore, TZD did not reduce NETs expression, a killing 
mechanism that may be particularly important to the health of the mammary gland. These 
direct effects of TZD on PMN function coupled with potential indirect effects of TZD on 
immunity via circulating metabolites suggest a potential important role for TZD in 
improving periparturient immune function and health.  
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APPENDIX A: ISOLATION OF BOVINE NEUTROPHILS FROM BLOOD 
Principle 
A prerequisite for experiments using bovine neutrophils is an adequate method of 
isolation of these cells from blood to obtain highly purified and functional cell 
populations (Soltys et al., 1999). Blood collection was performed using tubes containing 
acid citrate dextrose (ACD) because when different anticoagulants such as heparin are 
used, the buffy coat has a fibrin mesh-like membrane that interferes with leukocyte 
separation and may change their morphology and functionality (Carlson and Kaneko, 
1973). The most frequent technique used for separating granulocytes (also known as 
polymorphonuclear cells or PMNs), from peripheral blood is by discontinuous density 
centrifugation, first described by Boyum (1968). In this method, mononuclear leucocytes 
are first removed from peripheral blood by slow centrifugation using a density gradient 
medium. During centrifugation, cell subtypes will sediment to an equilibrium position in 
the gradient where the density gradient is equal to the density of the cells. To separate 
mononuclear cells from PMNs, a target density of 1.084 g/mL is used so that 
mononuclear cells, which have a density less than 1.084 g/mL will sediment on top of the 
density gradient medium while heavier cells such as PMNs (neutrophils, basophils, 
eosonophils) and erythrocytes cross the gradient. In a second step granulocytes are 
separated from erythrocytes by hypotonic shock (Figure 3.1). Purity of the neutrophil 
population, assessed by Giemsa staining and differential cell counting, was > 95% with 
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eosonophils being the major contaminant cell type. Neutrophil viability was > 97% as 
determined by Trypan Blue® exclusion. 
Reagents 
- Sterile PBS, pH 7.4 
8g of NaCl (Sigma Chemical cat. # S6191), 0.2g of KCl (Sigma Chemical cat. # 
P5405), 1.44g of Na2HPO4 (Sigma Chemical cat. # S5136) and 0.24g of KH2PO4 
(Sigma Chemical cat. # P5655) per L of solution  
- 1.5 M NaCl 
300 mL of 5 M NaCl (Fisher cat. # 9385658) per L of solution 
- 1.084 g/mL Percoll® (GE Healthcare Bio-Sciences cat. # 17-0891-01) 
601.54L of Percoll®, 298.46 mL of ddH2O and 100 mL of 1.5 M NaCl per L of 
solution 
- Lysing solution 10.56 mM Na2HPO4, 2.67 mM NaH2PO4 (Sigma Chemical cat. # 
S3139) 
- Restoring solution 10.56 mM Na2HPO4, 2.67 mM NaH2PO4 0.43 M NaCl  
- Ca-Mg-free Hank’s balanced salt solution (CMF-HBSS, Sigma Chemical cat. # 
H6648 ) 
- Trypan Blue (Sigma Chemical cat. # T8154) 




1. Transfer 10 mL of blood to a 50-mL polypropylene conical tube and centrifuge at 
1000×g for 20 min at 4°C to separate plasma from the cell pack.  
2. Discard plasma by aspiration and suspend the remaining cells in 35 mL of ice-cold 
PBS.  
3. Slowly pipette down this suspension to the side of a 50-mL polypropylene conical 
tube containing 10 mL of 1.084 g/mL of Percoll® without mixing.  
4. Centrifuge at 400 x g for 40 min at 22°C (slow acceleration, no brake).  
5. Discard by aspiration the supernatant, mononuclear cell layer and Percoll®  
6. Retain the pellet (PMN and erythrocytes) and lyse erythrocytes by adding 2 volumes 
of an ice-cold lysing solution for each volume of cell suspension. Mix gentle by 
aspiration and inversion. Restore tonicity by adding 1 volume of restoring solution. 
7. Centrifuge (500 x g) for 4 min at 4°C and wash the pellet washed twice by 
resuspension in 35 mL of CMF-HBSS and recentrifugation (500 x g for 3 min at 
4°C).  
8. Resuspend cells in 2-3 mL CMF-HBSS. Determine cell viability by Trypan Blue® 
following the instructions provided by the manufacturer. 
9. For differential counting, make a smear by placing a small drop of the cell suspension 
near the end of a glass slide and spread the sample using another slide or a coverslip 
so that the angle between them is 30-40 degrees.  
10. Fix the smear by immersion in 100% Methanol for 4 min. Let the smear dry and stain 




Percoll isolation of bovine neutrophils (A) and purified blood PMN (100 X, B) 
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APPENDIX B: TOTAL REACTIVE OXYGEN SPECIES PRODUCTION ASSAY 
(LUMINOL) 
Principle 
Luminol-derived chemiluminescence (CL) is elicited by several reactive oxygen species 
(ROS) including superoxide (O2-), hydroxyl radical (OH-), hydrogen peroxide (H2O2), 
peroxynitrite (ONOO-) and hypochlourus acid (HClO). Thus, the selective use of various 
scavengers, such as ebselen, uric acid, catalase, and superoxide dismutase (SOD), is 
necessary to determine which of these species is responsible for the signal produced by 
luminol (Munzel et al., 2002, Rinaldi et al., 2006b). Because luminol is a cell permeable 
compound, the ROS measured reflects their extracellular as well as intracellular 
production even though Rinaldi et al. (2006b) suggested that changes in PMN luminol-
dependant CL may not detect extracellular release of O2- and OH-. Upon neutrophil 
activation by PMA, the membrane-bound NADPH oxidase complex catalyze the 
consumption of O2 via electron transfer from NADPH to O2 resulting in the generation of 
O2─ which can be converted to H2O2, the main precursor of other neutrophil ROS. The 
enzyme myeloperoxidase then forms a complex with H2O2 that is either going to attack 
the pathogen directly or react with nitrogen intermediates. After exposure to ROS, the 
chemiluminescent probe luminol is oxidized under basic conditions with the release 
energy in the form of photons that can be detected by a luminometer: 
                                                           oxidation 




C8H7N3O2 + 2 OH-   Æ  C8H5NO42- + N2 + 2H2O + light 
Reagents 
- Ca-Mg-free Hank’s balanced salt solution (CMF-HBSS, Sigma Chemical cat. # 
H6648 ) 
- Dimethyl sulfoxide ≥ 99.5% GC (DMSO, Sigma Chemical cat. # D5879) 
- 5mM Luminol (5-amino-2,3-dihydro-1,4-phthalazinedione, Sigma Chemical cat. # 
A8511) 
Stock solution (89.4 mM): 3960 mg of luminol in 10 mL of DMSO 
Working solution (5 mM): 559.2 µL of stock in 10 mL of CMF-HBSS   
- 400 nM phorbol 12-myristate, 13-acetate ≥ 98.0% TLC (PMA, Sigma Chemical cat. # 
79346) 
Stock solution (162.117 µM): 1 mg of PMA in 10 mL of DMSO 
Working solution (400 nM): 24.67 µL of stock in 10 mL of CMF-HBSS   
Procedure 
1. Pre-warm all reagents at 37°C 
2. Pipette 2 x 105 cells per well suspended in CMF-HBSS in white/clear-bottom 96-
well plates with non-binding surface (Corning cat. #3604) 
3. Add 20 µL of 5mM Luminol  
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4. Adjust reaction volumes to 180 uL with CMF-HBSS 
5. Add 20 µL of either 400 nM phorbol 12-myristate, 13-acetate (PMA) (Stimulated 
cells) or CMF-HBSS (Control) 
6. Read plate every 5 or 10 for 190 min under the following parameters for every 
reading: 
Temperature setpoint: 37°C 
Shake: fast for 0:05 
Reading detection method: luminescence 
Read type: endpoint 
Integration time: 0.3SS.s 
Emission: hole 
Optics position: top 
Sensitivity: 115 
Top probe vertical offset: 1mm 
 
7. Substract background values, defined as the mean CL values of unactivated PMN. 
88 
 
APPENDIX C: EXTRACELLULAR O2- PRODUCTION ASSAY (MCLA) 
Principle 
Cypridina Luciferin methoxy-analogue [2-Methyl-6-(4-methoxyphenyl)-3,7-
dihydroimidazo [1,2-a]pyrazin-3(7H)-one hydrochloride, MCLA] dependant 
luminescence is a highly sensitive assay used to detect extracellular production of 
superoxide anion radical (O2-). The specificity of MCLA for O2- has been confirmed by 
complete inhibition of MCLA-derived CL by superoxide dismutase (SOD) (Rinaldi et al., 
2006b). On exposure to O2-, the chemiluminescent probe MCLA releases a photon that 
can be detected by a scintillation counter or a luminometer: 
C14H13N3O2 · HCl + O2- Æ C14H13N3O2 · HCl · 2OOH + light 
In CL measurements over time, the addition of MCLA to the reaction before each reading 
is necessary since it is rapidly consumed. 
Reagents 
- Ca-Mg-free Hank’s balanced salt solution (CMF-HBSS, Sigma Chemical cat. # 
H6648 ) 
- Dimethyl sulfoxide ≥ 99.5% GC (DMSO, Sigma Chemical cat. # D5879) 
- 2 µM MCLA (Cypridina Luciferin methoxy-analogue, Sigma Chemical cat. # 87787) 
- Stock solution (1371.1 µM): 10 mg of luminol in 25 mL of DMSO 
- Working solution (2 µM): 14.587 µL of stock in 10 mL of CMF-HBSS   
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- 400 nM phorbol 12-myristate, 13-acetate ≥ 98.0% TLC (PMA, Sigma Chemical cat. # 
79346) 
- Stock solution (162.117 µM): 1 mg of PMA in 10 mL of DMSO 
- Working solution (400 nM): 24.67 µL of stock in 10 mL of CMF-HBSS   
Procedure 
1. Pre-warm all reagents at 37°C 
2. Pipette 4 x 105 cells per well suspended in CMF-HBSS in white/clear-bottom 96-well 
plates with non-binding surface (Corning cat. #3604) 
3. Add 10 µL of 2 µM MCLA 
4. Adjust reaction volumes to 160 uL with CMF-HBSS 
5. Add 40 µL of either 400 nM phorbol 12-myristate, 13-acetate (PMA) (Stimulated 
cells) or CMF-HBSS (Control) 
6. Read the plate every 10 min for 80 min under the following parameters for every 
reading: 
Temperature setpoint: 37 C 
Shake: fast for 0:05 
Reading detection method: luminescence 
Read type: endpoint 
Integration time: 0.3SS.s 
Emission: hole 
Optics position: top 
Sensitivity: 115 
Top probe vertical offset: 1mm 
 
7. Add 10 µL of 2 µM MCLA 1 min before each reading 
8. Substract background values, defined as the mean CL values of unactivated PMN 
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APPENDIX D: INTRACELLULAR REACTIVE OXYGEN SPECIES 
PRODUCTION ASSAY (CM-H2DCFDA) 
Principle 
CM-H2DCFDA is a cell-permeant probe for ROS detection that are trapped 
intracellularly. It is nonfluorescent until removal of the acetate groups by intracellular 
esterases and oxidation that occurs within the cell (Rinaldi et al., 2006b). Fluorescence 
occurs when light is absorbed from an external source (485 nm excitation wavelength) by 
the fluorescent probe CM-H2DCFDA that undergoes its florescent properties due to its 
interaction with the ROS. In turn, the emitted light by the reaction has a wavelength of 
528 nm.:  
CM-H2DCFDA + [ROS released by PMNs] + light (485 nm)  Æ  [Products] + photon 
energy (528 nm) 
The intracellular ROS by measured by CM-H2DCFDA include hydrogen peroxide 
(H2O2), peroxynitrite anion (ONOO-) and nitric oxide. It has been shown that superoxide 
dismutase has no inhibitory effect on CM-H2DCFDA-dependant fluorescence suggesting 
that it specifically oxidizes intracellular ROS produced by bovine PMNs.  
Reagents 
- Ca-Mg-free Hank’s balanced salt solution (CMF-HBSS, Sigma Chemical cat. # 
H6648 ) 
- Dimethyl sulfoxide ≥ 99.5% GC (DMSO, Sigma Chemical cat. # D5879) 
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- 200 µM 5-(6)-chloromethyl-2',7'-dichlorodihydrofluorescein di-acetate acetyl ester 
(CM-H2DCFDA Invitrogen cat. # C6827)  
Stock solution (1730.7 µM): 1 mg of CM-H2DCFDA in 1 mL of DMSO 
Working solution (200 µM): 1 mL of stock in 8.654 mL of CMF-HBSS   
- 400 nM phorbol 12-myristate, 13-acetate ≥ 98.0% TLC (PMA, Sigma Chemical cat. # 
79346) 
Stock solution (162.117 µM): 1 mg of PMA in 10 mL of DMSO 
Working solution (400 nM): 24.67 µL of stock in 10 mL of CMF-HBSS   
Procedure 
1. Pre-warm all reagents at 37°C 
2. Pipette 4 x 105 cells per well suspended in CMF-HBSS in white/clear-bottom 96-well 
plates with non-binding surface (Corning cat. #3604) 
3. Add 10 µL of 200 µM CM-H2DCFDA 
4. Adjust reaction volumes to 170 uL with CMF-HBSS 
5. Add 30 µL of either 400 nM phorbol 12-myristate, 13-acetate (PMA) (Stimulated 
cells) or CMF-HBSS (Control) 
6. Read the plate every 5 or 10 min for 200 min under the following parameters for 
every reading: 
Temperature setpoint: 37 C 
Shake: fast for 0:05 
Reading detection method: fluorescence  
Read type: endpoint 




Optics position: top 
Sensitivity: 40 
 
7. Top probe vertical offset: 1mm 
8. Substract background values, defined as the mean CL values of unactivated PMN 
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APPENDIX E: NEUTROPHIL EXTRACELLULAR TRAPS (NETS) ASSAY 
Principle 
Neutrophil extracellular traps (NETs) are extracellular structures released by activated 
neutrophils. DNA is the major structural component of NETs but they also contain 
several antimicrobial proteins including elastase, cathepsin and myeloperoxidase 
(Brinkmann et al., 2004). NETs active formation can be quantified in a fluorometer with 
the use of a high-affinity DNA binding stain, such as Sytox® Orange, that will not cross 
the cell membrane of live cells. After incubation, the nucleic acids fluoresce bright 
orange when excited with a 520-550 nm source. Fluorescence can then be measured 
using a plate reader. 
Reagents 
- Ca-Mg-free Hank’s balanced salt solution (CMF-HBSS, Sigma Chemical cat. # 
H6648 ) 
- RPMI-1640 + 2% heat-inactivated FBS 
490 mL of Advanced RPMI 1640 Reduced Serum Medium 1X (+ non-essential 
aminoacids, + 110 mg/L sodium pyruvate, - L-glutamine; Invitrogen cat. #12633) + 
10 mL of heat inactivated Fetal Bovine Serum (FBS; Invitrogen cat. #10091)  
- 0.07 µg/mL phorbol 12-myristate, 13-acetate ≥ 98.0% TLC (PMA, Sigma Chemical 
cat. # 79346) 
Stock solution (162.117 µM): 1 mg of PMA in 10 mL of DMSO 
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Working solution (0.07 µg/mL): 28 µL of stock in 40 mL of RPMI-1640 + 2% 
heat-inactivated FBS 
- 7 µM Ionomycin from Streptomyces conglobatus ≥98% HPLC (Sigma cat. #I9657) 
Stock solution (0.1mg/mL): 1 mg of Ionomycin in 10 mL of DMSO 
Working solution (7 µM): 1985.2 µL of stock in 40 mL of RPMI-1640 + 2% heat-
inactivated FBS 
- 5 μM Sytox® Orange (5mM Invitrogen cat. # S11368) 
10 μL of Sytox® Orange 5mM in 10 mL of CMF-HBSS 
Procedure 
1. Pre-warm all reagents at 37°C 
2. Pipette 5 x 105 cells per well (100 µL) suspended in RPMI-1640 + 2% heat-
inactivated FBS in non-treated white/clear-bottom 96-well plates (Corning cat. 
#3632) 
3. Add 20 uL of either 0.07 µg/mL PMA and 7 µM ionomycin (stimulated cells) or 
RPMI-1640 + 2% heat-inactivated FBS (controls)  
4. Centrifuge the plates (10 min at 650 × g) and incubate at 37 °C and 5% CO2 for 60 
min. - Remove supernatant from the plates  
5. Stain the wells by adding 50 μl of 5 μM Sytox® Orange protected from light for 10 
min at room temperature 
6. Pour off the stain and wash the wells once with 100 μl of CMF-HBSS 
7. Read plate under the following parameters: 
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Shake: fast for 0:05 
Reading detection method: fluorescence  
Read type: endpoint 
Excitation : 530/25 
Emission: 590/35 
Optics position: bottom 
Sensitivity: 40 
Top probe vertical offset: 1mm 
 
8. Substract background values, defined as the mean CL values of unactivated PMN 
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APPENDIX F: PHAGOCYTOSIS AND KILLING ASSAY 
Principle 
Anti-microbial activity of neutrophils can be measured by colony-counting techniques 
after lysis of cells that contain viable bacteria. In a first step, neutrophils are incubated 
with a bacterial suspension, which concentration was previously adjusted, and heat-
inactivated bovine serum for a period of 1 hr. During this period, the phagocytes engulf 
and kill the pathogens by their intracellular and extracellular mechanisms. Then, an 
aliquot from this reaction is obtained to prepare smears to be analyzed under light 
microscopy to determine the number of intracellular bacteria (Figure 3.2). The reaction is 
further sonicated to disrupt the cell membrane and liberate the intracellular bacteria. This 
suspension can be serially diluted and used to determine the number of bacteria present in 
the reactions with neutrophils in comparison with those reactions only with bacteria. 
Reagents 
- Ca-Mg-free Hank’s balanced salt solution (CMF-HBSS, Sigma Chemical cat. # 
H6648) 
- Sterile PBS, pH 7.4 
8g of NaCl (Sigma Chemical cat. # S6191), 0.2g of KCl (Sigma Chemical cat. # 
P5405), 1.44g of Na2HPO4 (Sigma Chemical cat. # S5136) and 0.24g of KH2PO4 
(Sigma Chemical cat. # P5655) per L of solution  
- Brain-heart infusion broth (Sigma Chemical cat. # 53286) 
- Bovine Serum (Heat inactivated, Fisher Scientific cat. # 19135280) 
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- Giemsa® stain (Sigma Chemical cat. # G9641) 
Procedure 
1. Inoculate Staphylococcus aureus strain 305 on a blood agar plate and incubate 
overnight at 37°C.  
2. Transfer 10 colony forming units (cfu) from the plate to a sterile tube containing 10 
mL of brain–heart infusion broth (prepared according to instructions provided by the 
manufacturers) and incubate overnight at 37°C at 225 rpm in an orbital shaker.  
3. After incubation, place the tube in an ice-water bath and mixed by vortexing.  
4. Serially dilute 100 μL from the culture in PBS and spread 100 μL of the resulting 
dilutions on blood agar plates. Incubate the plates overnight at 37°C and maintain the 
stock culture at 4°C.  
5. Determine the concentration (cfu/mL) of the stock culture based on the colony counts 
of the spread plates.  
6. Dilute the stock culture in HBSS to yield a final concentration of 4 x 107 cfu/mL. 
7. Add 200 µL of this culture (8 x 106 cfu) to sterile tubes with or without 2 x 106 
neutrophils (1.4 mL) and 400 µL of pooled, heat-inactivated bovine serum (ratio of 
bacteria to neutrophils 4:1).  
8. Place the samples on an orbital shaker for 60 min at 37°C.  
9. After incubation, prepare a smear with a 50-µL aliquot of each reaction and stain with 
Giemsa stain (score the first 100 PMN encountered in the field of view of a light 
microscope as either positive or negative for intracellular bacteria; for those scored as 
positive, count the number of intracellular bacteria). 
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10. Place 1.95 mL of the remaining reaction in ice and sonicate with a sonic 
dismembrator (Model 100, Fisher Scientific) at a power setting of 1 for 15 s (Verify 
rupture of PMN by microscopic examination). 
11. Serial dilute 100 μL aliquot from each sonicated reaction in PBS and spread 100 μL 
quantities of the resulting dilutions on blood agar plates.  
12. Incubate the plates overnight at 37°C and enumerate the colonies.  
13. Determine the percentage of bacteria killed by calculating the difference in the 
number of bacteria incubated in the absence and presence of PMN and dividing this 
difference by the number of bacteria incubated in the absence of PMN. 
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